Stem cells and heart disease - Brake or accelerator?

Advanced Drug Delivery Reviews

Volumn 120, Issue , 2017, Pages 2-24

  Steinhoff, Gustav ^a   Nesteruk, Julia ^a   Wolfien, Markus ^b   Große, Jana ^a   Ruch, Ulrike ^a   Vasudevan, Praveen ^a   Müller, Paula ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Cardiac disease; EPC; HSC; MSC; Quality management; SH2B3; Stem cell; Systems medicine; Tissue repair

Indexed keywords

CARDIOLOGY; CLINICAL RESEARCH; CYTOLOGY; DATA SHARING; DISEASE CONTROL; DISEASES; HEART; QUALITY MANAGEMENT; REPAIR; TISSUE; TISSUE REGENERATION;

CARDIAC DISEASE; CLINICAL TRANSLATION; COMPUTATIONAL DATA; EXPERIMENTAL EVIDENCE; INTEGRATION OF KNOWLEDGE; SCIENTIFIC DEVELOPMENT; SH2B3; TISSUE REPAIR;

STEM CELLS;

ADAPTOR PROTEIN; BIOLOGICAL MARKER; SH2B3 ADAPTOR PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTIFICIAL INTELLIGENCE; CARDIAC MUSCLE CELL; CARDIAC STEM CELL; CELL FUNCTION; CELL INTERACTION; CELL RENEWAL; DATA ANALYSIS; DATA MINING; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; ENDOVENTRICULAR INTRAMYOCARDIAL INJECTION; FIBROSIS; HEALTH CENTER; HEART DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; INDUCED PLURIPOTENT STEM CELL; INFLAMMATION; INFLAMMATORY CELL; INTRACORONARY APPLICATION; INTRAMYOCARDIAL APPLICATION; ISCHEMIA; MEDICAL PRACTICE; MEDICAL PROCEDURES; MESENCHYMAL STEM CELL; NEXT GENERATION SEQUENCING; NONHUMAN; PERIPHERAL INTRAVENOUS INFUSION; PRIORITY JOURNAL; PROTEIN FUNCTION; QUALITY STANDARD; REGULATORY MECHANISM; RETROGRADE CORONARY SINUS INFUSION; REVIEW; STANDARD; STEM CELL; STEM CELL TRANSPLANTATION; TRANSEPICARDIAL APPLICATION; TRANSVASCULAR DELIVERY; VASCULARIZATION; ANIMAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; PROCEDURES;

ANIMALS; HEART DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; STEM CELL TRANSPLANTATION;

EID: 85033442790     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2017.10.007     Document Type: Review

References (376)

1. Stamm, C., Westphal, B., Kleine, H.-D., Petzsch, M., Kittner, C., Klinge, H., Schümichen, C., Nienaber, C.A., Freund, M., Steinhoff, G., Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361:9351 (2003), 45–46.
2. Steinhoff, G., Nesteruk, J., Wolfien, M., Kundt, G., Börgermann, J., David, R., Garbade, J., Große, J., Haverich, A., Hennig, H., Kaminski, A., Lotz, J., Mohr, F.-W., Müller, P., Oostendorp, R., Ruch, U., Sarikouch, S., Skorska, A., Stamm, C., Tiedemann, G., Wagner, F.M., Wolkenhauer, O., Cardiac function improvement and bone marrow response -: outcome analysis of the randomized PERFECT phase III clinical trial of intramyocardial CD133(+) application after myocardial infarction. EBioMedicine 22 (2017), 208–224.
3. Eglitis, M.A., Mezey, E., Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. U. S. A. 94:8 (1997), 4080–4085.
4. Theise, N.D., Nimmakayalu, M., Gardner, R., Illei, P.B., Morgan, G., Teperman, L., Henegariu, O., Krause, D.S., Liver from bone marrow in humans. Hepatology 32:1 (2000), 11–16.
5. Brazelton, T.R., Rossi, F.M., Keshet, G.I., Blau, H.M., From marrow to brain: expression of neuronal phenotypes in adult mice. Science (New York, N.Y.) 290:5497 (2000), 1775–1779.
6. Bittner, R.E., Schofer, C., Weipoltshammer, K., Ivanova, S., Streubel, B., Hauser, E., Freilinger, M., Hoger, H., Elbe-Burger, A., Wachtler, F., Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat. Embryol. 199:5 (1999), 391–396.
7. Steinhoff, G., Wonigeit, K., Schäfers, H.J., Haverich, A., Expression of monomorphic and polymorphic major histocompatibility complex determinants in human heart grafts. Transplant. Proc. 20:1 Suppl 1 (1988), 67–71.
8. Steinhoff, G., Wonigeit, K., Schäfers, H.J., Haverich, A., Sequential analysis of monomorphic and polymorphic major histocompatibility complex antigen expression in human heart allograft biopsy specimens. J. Heart Transplant. 8:5 (1989), 360–370.
9. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S.M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D.M., Leri, A., Anversa, P., Bone marrow cells regenerate infarcted myocardium. Nature 410:6829 (2001), 701–705.
10. Kocher, A.A., Schuster, M.D., Szabolcs, M.J., Takuma, S., Burkhoff, D., Wang, J., Homma, S., Edwards, N.M., Itescu, S., Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7:4 (2001), 430–436.
11. Eaves, C.J., Hematopoietic stem cells: concepts, definitions, and the new reality. Blood 125:17 (2015), 2605–2613.
12. Asahara, T., Isolation of putative progenitor endothelial cells for angiogenesis. Science (New York, N.Y.) 275:5302 (1997), 964–966.
13. Yoder, M.C., Human endothelial progenitor cells. Cold Spring Harb. Perspect. Med., 2(7), 2012, a006692.
14. Takizawa, S., Nagata, E., Nakayama, T., Masuda, H., Asahara, T., Recent progress in endothelial progenitor cell culture systems: potential for stroke therapy. Neurol. Med. Chir. 56:6 (2016), 302–309.
15. Korbling, M., Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?. Blood 98:10 (2001), 2900–2908.
16. Wojakowski, W., Tendera, M., Michalowska, A., Majka, M., Kucia, M., Maslankiewicz, K., Wyderka, R., Ochala, A., Ratajczak, M.Z., Mobilization of CD34/CXCR4 +, CD34/CD117 +, c-met + stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110:20 (2004), 3213–3220.
17. Wojakowski, W., Tendera, M., Zebzda, A., Michalowska, A., Majka, M., Kucia, M., Maslankiewicz, K., Wyderka, R., Krol, M., Ochala, A., Kozakiewicz, K., Ratajczak, M.Z., Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction. Eur. Heart J. 27:3 (2006), 283–289.
18. Massa, M., Rosti, V., Ferrario, M., Campanelli, R., Ramajoli, I., Rosso, R., de Ferrari, G.M., Ferlini, M., Goffredo, L., Bertoletti, A., Klersy, C., Pecci, A., Moratti, R., Tavazzi, L., Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105:1 (2005), 199–206.
19. Leone, A.M., Rutella, S., Bonanno, G., Abbate, A., Rebuzzi, A.G., Giovannini, S., Lombardi, M., Galiuto, L., Liuzzo, G., Andreotti, F., Lanza, G.A., Contemi, A.M., Leone, G., Crea, F., Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur. Heart J. 26:12 (2005), 1196–1204.
20. da Silva Meirelles, L., Caplan, A.I., Nardi, N.B., In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26:9 (2008), 2287–2299.
21. da Silva Meirelles, L., Chagastelles, P.C., Nardi, N.B., Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 119:Pt 11 (2006), 2204–2213.
22. Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., Ringdén, O., Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:9419 (2004), 1439–1441.
23. Quevedo, H.C., Hatzistergos, K.E., Oskouei, B.N., Feigenbaum, G.S., Rodriguez, J.E., Valdes, D., Pattany, P.M., Zambrano, J.P., Hu, Q., McNiece, I., Heldman, A.W., Hare, J.M., Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc. Natl. Acad. Sci. U. S. A. 106:33 (2009), 14022–14027.
24. Williams, A.R., Hatzistergos, K.E., Addicott, B., McCall, F., Carvalho, D., Suncion, V., Morales, A.R., Da Silva, J., Sussman, M.A., Heldman, A.W., Hare, J.M., Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 127:2 (2013), 213–223.
25. Beltrami, A.P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K., Leri, A., Kajstura, J., Nadal-Ginard, B., Anversa, P., Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:6 (2003), 763–776.
26. Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., de Angelis, A., Yasuzawa-Amano, S., Trofimova, I., Siggins, R.W., Lecapitaine, N., Cascapera, S., Beltrami, A.P., D'Alessandro, D.A., Zias, E., Quaini, F., Urbanek, K., Michler, R.E., Bolli, R., Kajstura, J., Leri, A., Anversa, P., Human cardiac stem cells. Proc. Natl. Acad. Sci. U. S. A. 104:35 (2007), 14068–14073.
27. Ellison, G.M., Vicinanza, C., Smith, A.J., Aquila, I., Leone, A., Waring, C.D., Henning, B.J., Stirparo, G.G., Papait, R., Scarfo, M., Agosti, V., Viglietto, G., Condorelli, G., Indolfi, C., Ottolenghi, S., Torella, D., Nadal-Ginard, B., Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 154:4 (2013), 827–842.
28. Laugwitz, K.-L., Moretti, A., Lam, J., Gruber, P., Chen, Y., Woodard, S., Lin, L.-Z., Cai, C.-L., Lu, M.M., Reth, M., Platoshyn, O., Yuan, J.X.-J., Evans, S., Chien, K.R., Postnatal isl1 + cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433:7026 (2005), 647–653.
29. Genead, R., Danielsson, C., Andersson, A.B., Corbascio, M., Franco-Cereceda, A., Sylven, C., Grinnemo, K.-H., Islet-1 cells are cardiac progenitors present during the entire lifespan: from the embryonic stage to adulthood. Stem Cells Dev. 19:10 (2010), 1601–1615.
30. Cai, C.-L., Liang, X., Shi, Y., Chu, P.-H., Pfaff, S.L., Chen, J., Evans, S., Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 5:6 (2003), 877–889.
31. Uchida, S., de Gaspari, P., Kostin, S., Jenniches, K., Kilic, A., Izumiya, Y., Shiojima, I., Grosse Kreymborg, K., Renz, H., Walsh, K., Braun, T., Sca1-derived cells are a source of myocardial renewal in the murine adult heart. Stem Cell Rep. 1:5 (2013), 397–410.
32. Wang, X., Hu, Q., Nakamura, Y., Lee, J., Zhang, G., From, A.H.L., Zhang, J., The role of the sca-1 +/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 24:7 (2006), 1779–1788.
33. Oh, H., Bradfute, S.B., Gallardo, T.D., Nakamura, T., Gaussin, V., Mishina, Y., Pocius, J., Michael, L.H., Behringer, R.R., Garry, D.J., Entman, M.L., Schneider, M.D., Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. U. S. A. 100:21 (2003), 12313–12318.
34. Malliaras, K., Li, T.-S., Luthringer, D., Terrovitis, J., Cheng, K., Chakravarty, T., Galang, G., Zhang, Y., Schoenhoff, F., van Eyk, J., Marban, L., Marban, E., Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation 125:1 (2012), 100–112.
35. Chimenti, I., Smith, R.R., Li, T.-S., Gerstenblith, G., Messina, E., Giacomello, A., Marban, E., Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ. Res. 106:5 (2010), 971–980.
36. White, A.J., Smith, R.R., Matsushita, S., Chakravarty, T., Czer, L.S.C., Burton, K., Schwarz, E.R., Davis, D.R., Wang, Q., Reinsmoen, N.L., Forrester, J.S., Marban, E., Makkar, R., Intrinsic cardiac origin of human cardiosphere-derived cells. Eur. Heart J. 34:1 (2013), 68–75.
37. Messina, E., de Angelis, L., Frati, G., Morrone, S., Chimenti, S., Fiordaliso, F., Salio, M., Battaglia, M., Latronico, M.V.G., Coletta, M., Vivarelli, E., Frati, L., Cossu, G., Giacomello, A., Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95:9 (2004), 911–921.
38. Pfister, O., Mouquet, F., Jain, M., Summer, R., Helmes, M., Fine, A., Colucci, W.S., Liao, R., CD31- but not CD31 + cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ. Res. 97:1 (2005), 52–61.
39. Martin, C.M., Meeson, A.P., Robertson, S.M., Hawke, T.J., Richardson, J.A., Bates, S., Goetsch, S.C., Gallardo, T.D., Garry, D.J., Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev. Biol. 265:1 (2004), 262–275.
40. Oyama, T., Nagai, T., Wada, H., Naito, A.T., Matsuura, K., Iwanaga, K., Takahashi, T., Goto, M., Mikami, Y., Yasuda, N., Akazawa, H., Uezumi, A., Takeda, S., Komuro, I., Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J. Cell Biol. 176:3 (2007), 329–341.
41. Hsieh, P.C.H., Segers, V.F.M., Davis, M.E., MacGillivray, C., Gannon, J., Molkentin, J.D., Robbins, J., Lee, R.T., Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat. Med. 13:8 (2007), 970–974.
42. Malliaras, K., Zhang, Y., Seinfeld, J., Galang, G., Tseliou, E., Cheng, K., Sun, B., Aminzadeh, M., Marban, E., Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol. Med. 5:2 (2013), 191–209.
43. Senyo, S.E., Steinhauser, M.L., Pizzimenti, C.L., Yang, V.K., Cai, L., Wang, M., Wu, T.-D., Guerquin-Kern, J.-L., Lechene, C.P., Lee, R.T., Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493:7432 (2013), 433–436.
44. Thomson, J.A., Embryonic stem cell lines derived from human blastocysts. Science 282:5391 (1998), 1145–1147.
45. Talkhabi, M., Aghdami, N., Baharvand, H., Human cardiomyocyte generation from pluripotent stem cells: a state-of-art. Life Sci. 145 (2016), 98–113.
46. Veerman, C.C., Kosmidis, G., Mummery, C.L., Casini, S., Verkerk, A.O., Bellin, M., Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem?. Stem Cells Dev. 24:9 (2015), 1035–1052.
47. Robertson, J.A., Human embryonic stem cell research: ethical and legal issues. Nat. Rev. Genet. 2:1 (2001), 74–78.
48. Nussbaum, J., Minami, E., Laflamme, M.A., Virag, J.A.I., Ware, C.B., Masino, A., Muskheli, V., Pabon, L., Reinecke, H., Murry, C.E., Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J. 21:7 (2007), 1345–1357.
49. Swijnenburg, R.-J., Tanaka, M., Vogel, H., Baker, J., Kofidis, T., Gunawan, F., Lebl, D.R., Caffarelli, A.D., de Bruin, J.L., Fedoseyeva, E.V., Robbins, R.C., Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112:9 Suppl (2005), I166–72.
50. Nouspikel, T., Genetic instability in human embryonic stem cells: prospects and caveats. Future Oncol. 9:6 (2013), 867–877.
51. Ilic, D., Ogilvie, C., Concise review: human embryonic stem cells-what have we done? What are we doing? Where are we going?. Stem Cells 35:1 (2017), 17–25.
52. Min, J.-Y., Yang, Y., Converso, K.L., Liu, L., Huang, Q., Morgan, J.P., Xiao, Y.-F., Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol. 92:1 (2002), 288–296.
53. Behfar, A., Zingman, L.V., Hodgson, D.M., Rauzier, J.-M., Kane, G.C., Terzic, A., Puceat, M., Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 16:12 (2002), 1558–1566.
54. Caspi, O., Huber, I., Kehat, I., Habib, M., Arbel, G., Gepstein, A., Yankelson, L., Aronson, D., Beyar, R., Gepstein, L., Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 50:19 (2007), 1884–1893.
55. Blin, G., Nury, D., Stefanovic, S., Neri, T., Guillevic, O., Brinon, B., Bellamy, V., Rucker-Martin, C., Barbry, P., Bel, A., Bruneval, P., Cowan, C., Pouly, J., Mitalipov, S., Gouadon, E., Binder, P., Hagege, A., Desnos, M., Renaud, J.-F., Menasche, P., Puceat, M., A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J. Clin. Invest. 120:4 (2010), 1125–1139.
56. Shiba, Y., Fernandes, S., Zhu, W.-Z., Filice, D., Muskheli, V., Kim, J., Palpant, N.J., Gantz, J., Moyes, K.W., Reinecke, H., van Biber, B., Dardas, T., Mignone, J.L., Izawa, A., Hanna, R., Viswanathan, M., Gold, J.D., Kotlikoff, M.I., Sarvazyan, N., Kay, M.W., Murry, C.E., Laflamme, M.A., Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489:7415 (2012), 322–325.
57. Laflamme, M.A., Gold, J., Xu, C., Hassanipour, M., Rosler, E., Police, S., Muskheli, V., Murry, C.E., Formation of human myocardium in the rat heart from human embryonic stem cells. Am. J. Pathol. 167:3 (2005), 663–671.
58. van Laake, L.W., Passier, R., Monshouwer-Kloots, J., Verkleij, A.J., Lips, D.J., Freund, C., den Ouden, K., Ward-van Oostwaard, D., Korving, J., Tertoolen, L.G., van Echteld, C.J., Doevendans, P.A., Mummery, C.L., Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 1:1 (2007), 9–24.
59. Laflamme, M.A., Chen, K.Y., Naumova, A.V., Muskheli, V., Fugate, J.A., Dupras, S.K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., O'Sullivan, C., Collins, L., Chen, Y., Minami, E., Gill, E.A., Ueno, S., Yuan, C., Gold, J., Murry, C.E., Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25:9 (2007), 1015–1024.
60. Yeghiazarians, Y., Gaur, M., Zhang, Y., Sievers, R.E., Ritner, C., Prasad, M., Boyle, A., Bernstein, H.S., Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition. Cytotherapy 14:2 (2012), 223–231.
61. Tomescot, A., Leschik, J., Bellamy, V., Dubois, G., Messas, E., Bruneval, P., Desnos, M., Hagege, A.A., Amit, M., Itskovitz, J., Menasche, P., Puceat, M., Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. Stem Cells 25:9 (2007), 2200–2205.
62. Chong, J.J.H., Yang, X., Don, C.W., Minami, E., Liu, Y.-W., Weyers, J.J., Mahoney, W.M., van Biber, B., Cook, S.M., Palpant, N.J., Gantz, J.A., Fugate, J.A., Muskheli, V., Gough, G.M., Vogel, K.W., Astley, C.A., Hotchkiss, C.E., Baldessari, A., Pabon, L., Reinecke, H., Gill, E.A., Nelson, V., Kiem, H.-P., Laflamme, M.A., Murry, C.E., Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510:7504 (2014), 273–277.
63. Ménard, C., Hagège, A.A., Agbulut, O., Barro, M., Morichetti, M.C., Brasselet, C., Bel, A., Messas, E., Bissery, A., Bruneval, P., Desnos, M., Pucéat, M., Menasché, P., Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 366:9490 (2005), 1005–1012.
64. Menasche, P., Vanneaux, V., Hagege, A., Bel, A., Cholley, B., Cacciapuoti, I., Parouchev, A., Benhamouda, N., Tachdjian, G., Tosca, L., Trouvin, J.-H., Fabreguettes, J.-R., Bellamy, V., Guillemain, R., Suberbielle Boissel, C., Tartour, E., Desnos, M., Larghero, J., Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur. Heart J. 36:30 (2015), 2011–2017.
65. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:4 (2006), 663–676.
66. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:5 (2007), 861–872.
67. Pfannkuche, K., Liang, H., Hannes, T., Xi, J., Fatima, A., Nguemo, F., Matzkies, M., Wernig, M., Jaenisch, R., Pillekamp, F., Halbach, M., Schunkert, H., Saric, T., Hescheler, J., Reppel, M., Cardiac myocytes derived from murine reprogrammed fibroblasts: intact hormonal regulation, cardiac ion channel expression and development of contractility. Cell. Physiol. Biochem. 24:1–2 (2009), 73–86.
68. Kong, C.-W., Akar, F.G., Li, R.A., Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models. Thromb. Haemost. 104:1 (2010), 30–38.
69. Poon, E., Kong, C.-W., Li, R.A., Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective. Mol. Pharm. 8:5 (2011), 1495–1504.
70. Yang, X., Pabon, L., Murry, C.E., Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Res. 114:3 (2014), 511–523.
71. Hartman, M.E., Dai, D.-F., Laflamme, M.A., Human pluripotent stem cells: prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Adv. Drug Deliv. Rev. 96 (2016), 3–17.
72. Barbuti, A., Benzoni, P., Campostrini, G., Dell'Era, P., Human derived cardiomyocytes: a decade of knowledge after the discovery of induced pluripotent stem cells. Dev. Dyn. 245:12 (2016), 1145–1158.
73. Narazaki, G., Uosaki, H., Teranishi, M., Okita, K., Kim, B., Matsuoka, S., Yamanaka, S., Yamashita, J.K., Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118:5 (2008), 498–506.
74. Mauritz, C., Schwanke, K., Reppel, M., Neef, S., Katsirntaki, K., Maier, L.S., Nguemo, F., Menke, S., Haustein, M., Hescheler, J., Hasenfuss, G., Martin, U., Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118:5 (2008), 507–517.
75. Kuzmenkin, A., Liang, H., Xu, G., Pfannkuche, K., Eichhorn, H., Fatima, A., Luo, H., Saric, T., Wernig, M., Jaenisch, R., Hescheler, J., Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. FASEB J. 23:12 (2009), 4168–4180.
76. Zhang, J., Wilson, G.F., Soerens, A.G., Koonce, C.H., Yu, J., Palecek, S.P., Thomson, J.A., Kamp, T.J., Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104:4 (2009), e30–41.
77. Ma, J., Guo, L., Fiene, S.J., Anson, B.D., Thomson, J.A., Kamp, T.J., Kolaja, K.L., Swanson, B.J., January, C.T., High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am. J. Physiol. Heart Circ. Physiol. 301:5 (2011), H2006–17.
78. Zwi, L., Caspi, O., Arbel, G., Huber, I., Gepstein, A., Park, I.-H., Gepstein, L., Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120:15 (2009), 1513–1523.
79. Burridge, P.W., Zambidis, E.T., Highly efficient directed differentiation of human induced pluripotent stem cells into cardiomyocytes. Methods Mol. Biol. 997 (2013), 149–161.
80. Kawamura, M., Miyagawa, S., Miki, K., Saito, A., Fukushima, S., Higuchi, T., Kawamura, T., Kuratani, T., Daimon, T., Shimizu, T., Okano, T., Sawa, Y., Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126:11 Suppl 1 (2012), S29–37.
81. Citro, L., Naidu, S., Hassan, F., Kuppusamy, M.L., Kuppusamy, P., Angelos, M.G., Khan, M., Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction. PLoS One, 9(12), 2014, e116281.
82. Zhang, L., Guo, J., Zhang, P., Xiong, Q., Wu, S.C., Xia, L., Roy, S.S., Tolar, J., O'Connell, T.D., Kyba, M., Liao, K., Zhang, J., Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast. Circ. Heart Fail. 8:1 (2015), 156–166.
83. Ye, L., Chang, Y.-H., Xiong, Q., Zhang, P., Zhang, L., Somasundaram, P., Lepley, M., Swingen, C., Su, L., Wendel, J.S., Guo, J., Jang, A., Rosenbush, D., Greder, L., Dutton, J.R., Zhang, J., Kamp, T.J., Kaufman, D.S., Ge, Y., Zhang, J., Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell 15:6 (2014), 750–761.
84. Carpenter, L., Carr, C., Yang, C.T., Stuckey, D.J., Clarke, K., Watt, S.M., Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. Stem Cells Dev. 21:6 (2012), 977–986.
85. Mauritz, C., Martens, A., Rojas, S.V., Schnick, T., Rathert, C., Schecker, N., Menke, S., Glage, S., Zweigerdt, R., Haverich, A., Martin, U., Kutschka, I., Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur. Heart J. 32:21 (2011), 2634–2641.
86. Martens, A., Kensah, G., Rojas, S., Rotärmel, A., Baraki, H., Haverich, A., Martin, U., Gruh, I., Kutschka, I., Induced pluripotent stem cell (iPSC)-derived cardiomyocytes engraft and improve heart function in a mouse model of acute myocardial infarction. Thorac. Cardiovasc. Surg., 60(S 01), 2012.
87. Singh, V.K., Kumar, N., Kalsan, M., Saini, A., Chandra, R., Mechanism of induction: induced pluripotent stem cells (iPSCs). J. Stem Cells 10:1 (2015), 43–62.
88. Zhao, T., Zhang, Z.-N., Rong, Z., Xu, Y., Immunogenicity of induced pluripotent stem cells. Nature 474:7350 (2011), 212–215.
89. Boyd, A.S., Rodrigues, N.P., Lui, K.O., Fu, X., Xu, Y., Concise review: immune recognition of induced pluripotent stem cells. Stem Cells 30:5 (2012), 797–803.
90. Kaneko, S., Yamanaka, S., To be immunogenic, or not to be: that's the iPSC question. Cell Stem Cell 12:4 (2013), 385–386.
91. Polo, J.M., Liu, S., Figueroa, M.E., Kulalert, W., Eminli, S., Tan, K.Y., Apostolou, E., Stadtfeld, M., Li, Y., Shioda, T., Natesan, S., Wagers, A.J., Melnick, A., Evans, T., Hochedlinger, K., Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 28:8 (2010), 848–855.
92. Doi, A., Park, I.-H., Wen, B., Murakami, P., Aryee, M.J., Irizarry, R., Herb, B., Ladd-Acosta, C., Rho, J., Loewer, S., Miller, J., Schlaeger, T., Daley, G.Q., Feinberg, A.P., Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41:12 (2009), 1350–1353.
93. Lister, R., Pelizzola, M., Kida, Y.S., Hawkins, R.D., Nery, J.R., Hon, G., Antosiewicz-Bourget, J., O'Malley, R., Castanon, R., Klugman, S., Downes, M., Yu, R., Stewart, R., Ren, B., Thomson, J.A., Evans, R.M., Ecker, J.R., Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471:7336 (2011), 68–73.
94. Gore, A., Li, Z., Fung, H.-L., Young, J.E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M.A., Kiskinis, E., Lee, J.-H., Loh, Y.-H., Manos, P.D., Montserrat, N., Panopoulos, A.D., Ruiz, S., Wilbert, M.L., Yu, J., Kirkness, E.F., Izpisua Belmonte, J.C., Rossi, D.J., Thomson, J.A., Eggan, K., Daley, G.Q., Goldstein, L.S.B., Zhang, K., Somatic coding mutations in human induced pluripotent stem cells. Nature 471:7336 (2011), 63–67.
95. Yoshihara, M., Hayashizaki, Y., Murakawa, Y., Genomic instability of iPSCs: challenges towards their clinical applications. Stem Cell Rev., 2016.
96. Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K.Y., Lanza, R., Kim, K.-S., Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4:6 (2009), 472–476.
97. Zhou, H., Wu, S., Joo, J.Y., Zhu, S., Han, D.W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., Siuzdak, G., Scholer, H.R., Duan, L., Ding, S., Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4:5 (2009), 381–384.
98. Warren, L., Manos, P.D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P.K., Smith, Z.D., Meissner, A., Daley, G.Q., Brack, A.S., Collins, J.J., Cowan, C., Schlaeger, T.M., Rossi, D.J., Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7:5 (2010), 618–630.
99. Miyoshi, N., Ishii, H., Nagano, H., Haraguchi, N., Dewi, D.L., Kano, Y., Nishikawa, S., Tanemura, M., Mimori, K., Tanaka, F., Saito, T., Nishimura, J., Takemasa, I., Mizushima, T., Ikeda, M., Yamamoto, H., Sekimoto, M., Doki, Y., Mori, M., Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8:6 (2011), 633–638.
100. Anokye-Danso, F., Trivedi, C.M., Juhr, D., Gupta, M., Cui, Z., Tian, Y., Zhang, Y., Yang, W., Gruber, P.J., Epstein, J.A., Morrisey, E.E., Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8:4 (2011), 376–388.
101. Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., Ge, J., Xu, J., Zhang, Q., Zhao, Y., Deng, H., Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science (New York, N.Y.) 341:6146 (2013), 651–654.
102. Kang, P.J., Moon, J.-H., Yoon, B.S., Hyeon, S., Jun, E.K., Park, G., Yun, W., Park, J., Park, M., Kim, A., Whang, K.Y., Koh, G.Y., Oh, S., You, S., Reprogramming of mouse somatic cells into pluripotent stem-like cells using a combination of small molecules. Biomaterials 35:26 (2014), 7336–7345.
103. Zhao, Y., Zhao, T., Guan, J., Zhang, X., Fu, Y., Ye, J., Zhu, J., Meng, G., Ge, J., Yang, S., Cheng, L., Du, Y., Zhao, C., Wang, T., Su, L., Yang, W., Deng, H., A XEN-like state bridges somatic cells to pluripotency during chemical reprogramming. Cell 163:7 (2015), 1678–1691.
104. Strauer, B.-E., Steinhoff, G., 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J. Am. Coll. Cardiol. 58:11 (2011), 1095–1104.
105. Strauer, B.E., Brehm, M., Zeus, T., Kostering, M., Hernandez, A., Sorg, R.V., Kogler, G., Wernet, P., Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:15 (2002), 1913–1918.
106. Szilvassy, S.J., Bass, M.J., van Zant, G., Grimes, B., Organ-selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by ex vivo expansion. Blood 93:5 (1999), 1557–1566.
107. Kamota, T., Li, T.-S., Morikage, N., Murakami, M., Ohshima, M., Kubo, M., Kobayashi, T., Mikamo, A., Ikeda, Y., Matsuzaki, M., Hamano, K., Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J. Am. Coll. Cardiol. 53:19 (2009), 1814–1822.
108. Elmadbouh, I., Haider, H.K., Jiang, S., Idris, N.M., Lu, G., Ashraf, M., Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J. Mol. Cell. Cardiol. 42:4 (2007), 792–803.
109. Jiang, Q., Song, P., Wang, E., Li, J., Hu, S., Zhang, H., Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells. J. Mol. Cell. Cardiol. 56 (2013), 1–7.
110. Sussman, M., Cardiovascular biology. Hearts and bones. Nature 410:6829 (2001), 640–641.
111. Loffredo, F.S., Steinhauser, M.L., Gannon, J., Lee, R.T., Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 8:4 (2011), 389–398.
112. Fuchs, S., Baffour, R., Zhou, Y.F., Shou, M., Pierre, A., Tio, F.O., Weissman, N.J., Leon, M.B., Epstein, S.E., Kornowski, R., Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J. Am. Coll. Cardiol. 37:6 (2001), 1726–1732.
113. Galinanes, M., Loubani, M., Davies, J., Chin, D., Pasi, J., Bell, P.R., Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant. 13:1 (2004), 7–13.
114. Furlani, D., Ugurlucan, M., Ong, L., Bieback, K., Pittermann, E., Westien, I., Wang, W., Yerebakan, C., Li, W., Gaebel, R., Li, R.-K., Vollmar, B., Steinhoff, G., Ma, N., Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc. Res. 77:3 (2009), 370–376.
115. de La Fuente, L.M., Stertzer, S.H., Argentieri, J., Peñaloza, E., Miano, J., Koziner, B., Bilos, C., Altman, P.A., Transendocardial autologous bone marrow in chronic myocardial infarction using a helical needle catheter: 1-year follow-up in an open-label, nonrandomized, single-center pilot study (the TABMMI study). Am. Heart J., 154(1), 2007 (79.e1-7).
116. Trachtenberg, B., Velazquez, D.L., Williams, A.R., McNiece, I., Fishman, J., Nguyen, K., Rouy, D., Altman, P., Schwarz, R., Mendizabal, A., Oskouei, B., Byrnes, J., Soto, V., Tracy, M., Zambrano, J.P., Heldman, A.W., Hare, J.M., Rationale and design of the transendocardial injection of autologous human cells (bone marrow or mesenchymal) in chronic ischemic left ventricular dysfunction and heart failure secondary to myocardial infarction (TAC-HFT) trial: a randomized, double-blind, placebo-controlled study of safety and efficacy. Am. Heart J. 161:3 (2011), 487–493.
117. Behfar, A., Latere, J.-P., Bartunek, J., Homsy, C., Daro, D., Crespo-Diaz, R.J., Stalboerger, P.G., Steenwinckel, V., Seron, A., Redfield, M.M., Terzic, A., Optimized delivery system achieves enhanced endomyocardial stem cell retention. Circ. Cardiovasc. Interv. 6:6 (2013), 710–718.
118. Perin, E.C., Dohmann, H.F.R., Borojevic, R., Silva, S.A., Sousa, A.L.S., Mesquita, C.T., Rossi, M.I.D., Carvalho, A.C., Dutra, H.S., Dohmann, H.J.F., Silva, G.V., Belem, L., Vivacqua, R., Rangel, F.O.D., Esporcatte, R., Geng, Y.J., Vaughn, W.K., Assad, J.A.R., Mesquita, E.T., Willerson, J.T., Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107:18 (2003), 2294–2302.
119. Losordo, D.W., Schatz, R.A., White, C.J., Udelson, J.E., Veereshwarayya, V., Durgin, M., Poh, K.K., Weinstein, R., Kearney, M., Chaudhry, M., Burg, A., Eaton, L., Heyd, L., Thorne, T., Shturman, L., Hoffmeister, P., Story, K., Zak, V., Dowling, D., Traverse, J.H., Olson, R.E., Flanagan, J., Sodano, D., Murayama, T., Kawamoto, A., Kusano, K.F., Wollins, J., Welt, F., Shah, P., Soukas, P., Asahara, T., Henry, T.D., Intramyocardial transplantation of autologous CD34 + stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 115:25 (2007), 3165–3172.
120. Dib, N., Michler, R.E., Pagani, F.D., Wright, S., Kereiakes, D.J., Lengerich, R., Binkley, P., Buchele, D., Anand, I., Swingen, C., Di Carli, M.F., Thomas, J.D., Jaber, W.A., Opie, S.R., Campbell, A., McCarthy, P., Yeager, M., Dilsizian, V., Griffith, B.P., Korn, R., Kreuger, S.K., Ghazoul, M., MacLellan, W.R., Fonarow, G., Eisen, H.J., Dinsmore, J., Diethrich, E., Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 112:12 (2005), 1748–1755.
121. Stamm, C., Kleine, H.-D., Choi, Y.-H., Dunkelmann, S., Lauffs, J.-A., Lorenzen, B., David, A., Liebold, A., Nienaber, C., Zurakowski, D., Freund, M., Steinhoff, G., Intramyocardial delivery of CD133 + bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J. Thorac. Cardiovasc. Surg. 133:3 (2007), 717–725.
122. Klein, H.M., Ghodsizad, A., Marktanner, R., Poll, L., Voelkel, T., Mohammad Hasani, M.R., Piechaczek, C., Feifel, N., Stockschlaeder, M., Burchardt, E.R., Kar, B.J., Gregoric, I., Gams, E., Intramyocardial implantation of CD133 + stem cells improved cardiac function without bypass surgery. Heart Surg. Forum 10:1 (2007), E66–9.
123. Pompilio, G., Steinhoff, G., Liebold, A., Pesce, M., Alamanni, F., Capogrossi, M.C., Biglioli, P., Direct minimally invasive intramyocardial injection of bone marrow-derived AC133 + stem cells in patients with refractory ischemia: preliminary results. Thorac. Cardiovasc. Surg. 56:2 (2008), 71–76.
124. Bel, A., Planat-Bernard, V., Saito, A., Bonnevie, L., Bellamy, V., Sabbah, L., Bellabas, L., Brinon, B., Vanneaux, V., Pradeau, P., Peyrard, S., Larghero, J., Pouly, J., Binder, P., Garcia, S., Shimizu, T., Sawa, Y., Okano, T., Bruneval, P., Desnos, M., Hagège, A.A., Casteilla, L., Pucéat, M., Menasché, P., Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation 122:11 Suppl (2010), S118–23.
125. Hamdi, H., Planat-Benard, V., Bel, A., Neamatalla, H., Saccenti, L., Calderon, D., Bellamy, V., Bon, M., Perrier, M.-C., Mandet, C., Bruneval, P., Casteilla, L., Hagège, A.A., Pucéat, M., Agbulut, O., Menasché, P., Long-term functional benefits of epicardial patches as cell carriers. Cell Transplant. 23:1 (2014), 87–96.
126. Hamdi, H., Planat-Benard, V., Bel, A., Puymirat, E., Geha, R., Pidial, L., Nematalla, H., Bellamy, V., Bouaziz, P., Peyrard, S., Casteilla, L., Bruneval, P., Hagège, A.A., Agbulut, O., Menasché, P., Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections. Cardiovasc. Res. 91:3 (2011), 483–491.
127. Thompson, C.A., Nasseri, B.A., Makower, J., Houser, S., McGarry, M., Lamson, T., Pomerantseva, I., Chang, J.Y., Gold, H.K., Vacanti, J.P., Oesterle, S.N., Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J. Am. Coll. Cardiol. 41:11 (2003), 1964–1971.
128. George, J.C., Goldberg, J., Joseph, M., Abdulhameed, N., Crist, J., Das, H., Pompili, V.J., Transvenous intramyocardial cellular delivery increases retention in comparison to intracoronary delivery in a porcine model of acute myocardial infarction. J. Interv. Cardiol. 21:5 (2008), 424–431.
129. Wang, X., Jameel, M.N., Li, Q., Mansoor, A., Qiang, X., Swingen, C., Panetta, C., Zhang, J., Stem cells for myocardial repair with use of a transarterial catheter. Circulation 120:11 Suppl (2009), S238–46.
130. Medicetty, S., Wiktor, D., Lehman, N., Raber, A., Popovic, Z.B., Deans, R., Ting, A.E., Penn, M.S., Percutaneous adventitial delivery of allogeneic bone marrow-derived stem cells via infarct-related artery improves long-term ventricular function in acute myocardial infarction. Cell Transplant. 21:6 (2012), 1109–1120.
131. Siminiak, T., Burchardt, P., Kurpisz, M., Postinfarction heart failure: surgical and trans-coronary-venous transplantation of autologous myoblasts. Nat. Clin. Pract. Cardiovasc. Med. 3:Suppl. 1 (2006), S46–51.
132. Patel, A.N., Mittal, S., Turan, G., Winters, A.A., Henry, T.D., Ince, H., Trehan, N., REVIVE trial: retrograde delivery of autologous bone marrow in patients with heart failure. Stem Cells Transl. Med. 4:9 (2015), 1021–1027.
133. Tuma, J., Fernández-Viña, R., Carrasco, A., Castillo, J., Cruz, C., Carrillo, A., Ercilla, J., Yarleque, C., Cunza, J., Henry, T.D., Patel, A.N., Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina. J. Transl. Med., 9, 2011, 183.
134. Zakharova, L., Nural-Guvener, H., Feehery, L., Popovic, S., Nimlos, J., Gaballa, M.A., Retrograde coronary vein infusion of cardiac explant-derived c-Kit + cells improves function in ischemic heart failure. J Heart Lung Transplant 33:6 (2014), 644–653.
135. Dib, N., Khawaja, H., Varner, S., McCarthy, M., Campbell, A., Cell therapy for cardiovascular disease: a comparison of methods of delivery. J. Cardiovasc. Transl. Res. 4:2 (2011), 177–181.
136. Hong, S.J., Hou, D., Brinton, T.J., Johnstone, B., Feng, D., Rogers, P., Fearon, W.F., Yock, P., March, K.L., Intracoronary and retrograde coronary venous myocardial delivery of adipose-derived stem cells in swine infarction lead to transient myocardial trapping with predominant pulmonary redistribution. Catheter. Cardiovasc. Interv. 83:1 (2014), E17–25.
137. Halkos, M.E., Zhao, Z.-Q., Kerendi, F., Wang, N.-P., Jiang, R., Schmarkey, L.S., Martin, B.J., Quyyumi, A.A., Few, W.L., Kin, H., Guyton, R.A., Vinten-Johansen, J., Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res. Cardiol. 103:6 (2008), 525–536.
138. Hare, J.M., Traverse, J.H., Henry, T.D., Dib, N., Strumpf, R.K., Schulman, S.P., Gerstenblith, G., DeMaria, A.N., Denktas, A.E., Gammon, R.S., Hermiller, J.B. Jr., Reisman, M.A., Schaer, G.L., Sherman, W., A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54:24 (2009), 2277–2286.
139. Wang, W., Jiang, Q., Zhang, H., Jin, P., Yuan, X., Wei, Y., Hu, S., Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model. Regen. Med. 6:2 (2011), 179–190.
140. Giordano, F.J., Oxygen, oxidative stress, hypoxia, and heart failure. J. Clin. Invest. 115:3 (2005), 500–508.
141. Rose, B.A., Yokota, T., Chintalgattu, V., Ren, S., Iruela-Arispe, L., Khakoo, A.Y., Minamisawa, S., Wang, Y., Cardiac myocyte p38α kinase regulates angiogenesis via myocyte-endothelial cell cross-talk during stress-induced remodeling in heart. J. Biol. Chem., 2017.
142. Madeddu, P., Emanueli, C., Switching on reparative angiogenesis: essential role of the vascular erythropoietin receptor. Circ. Res. 100:5 (2007), 599–601.
143. Crisan, M., Corselli, M., Chen, W.C.W., Péault, B., Perivascular cells for regenerative medicine. J. Cell. Mol. Med. 16:12 (2012), 2851–2860.
144. Makkar, R.R., Smith, R.R., Cheng, K., Malliaras, K., Thomson, L.E.J., Berman, D., Czer, L.S.C., Marbán, L., Mendizabal, A., Johnston, P.V., Russell, S.D., Schuleri, K.H., Lardo, A.C., Gerstenblith, G., Marbán, E., Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379:9819 (2012), 895–904.
145. Qiao, W., Wang, W., Laurenti, E., Turinsky, A.L., Wodak, S.J., Bader, G.D., Dick, J.E., Zandstra, P.W., Intercellular network structure and regulatory motifs in the human hematopoietic system. Mol. Syst. Biol., 10, 2014, 741.
146. Rohban, R., Prietl, B., Pieber, T.R., Crosstalk between stem and progenitor cellular mediators with special emphasis on vasculogenesis. Transfus. Med. Hemother. 44:3 (2017), 174–182.
147. Kramann, R., Humphreys, B.D., Kidney pericytes: roles in regeneration and fibrosis. Semin. Nephrol. 34:4 (2014), 374–383.
148. Ceradini, D.J., Kulkarni, A.R., Callaghan, M.J., Tepper, O.M., Bastidas, N., Kleinman, M.E., Capla, J.M., Galiano, R.D., Levine, J.P., Gurtner, G.C., Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10:8 (2004), 858–864.
149. Lee, H.J., Ryu, J.M., Jung, Y.H., Oh, S.Y., Lee, S.-J., Han, H.J., Novel pathway for hypoxia-induced proliferation and migration in human mesenchymal stem cells: involvement of HIF-1α, FASN, and mTORC1. Stem Cells 33:7 (2015), 2182–2195.
150. Urao, N., Ushio-Fukai, M., Redox regulation of stem/progenitor cells and bone marrow niche. Free Radic. Biol. Med. 54 (2013), 26–39.
151. Lobov, I.B., Rao, S., Carroll, T.J., Vallance, J.E., Ito, M., Ondr, J.K., Kurup, S., Glass, D.A., Patel, M.S., Shu, W., Morrisey, E.E., McMahon, A.P., Karsenty, G., Lang, R.A., WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437:7057 (2005), 417–421.
152. Moon, H.E., Byun, K., Park, H.W., Kim, J.H., Hur, J., Park, J.S., Jun, J.K., Kim, H.-S., Paek, S.L., Kim, I.K., Hwang, J.H., Kim, J.W., Kim, D.G., Sung, Y.C., Koh, G.-Y., Song, C.W., Lee, B., Paek, S.H., COMP-Ang1 potentiates EPC treatment of ischemic brain injury by enhancing angiogenesis through activating AKT-mTOR pathway and promoting vascular migration through activating Tie2-FAK pathway. Exp. Neurobiol. 24:1 (2015), 55–70.
153. Plaks, V., Birnberg, T., Berkutzki, T., Sela, S., BenYashar, A., Kalchenko, V., Mor, G., Keshet, E., Dekel, N., Neeman, M., Jung, S., Uterine DCs are crucial for decidua formation during embryo implantation in mice. J. Clin. Invest. 118:12 (2008), 3954–3965.
154. Pollard, J.W., Trophic macrophages in development and disease. Nat. Rev. Immunol. 9:4 (2009), 259–270.
155. Oerlemans, M.I.F.J., Koudstaal, S., Chamuleau, S.A., de Kleijn, D.P., Doevendans, P.A., Sluijter, J.P.G., Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. Int. J. Cardiol. 165:3 (2013), 410–422.
156. Arslan, F., Smeets, M.B., O'Neill, L.A.J., Keogh, B., McGuirk, P., Timmers, L., Tersteeg, C., Hoefer, I.E., Doevendans, P.A., Pasterkamp, G., de Kleijn, D.P.V., Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 121:1 (2010), 80–90.
157. Epelman, S., Lavine, K.J., Beaudin, A.E., Sojka, D.K., Carrero, J.A., Calderon, B., Brija, T., Gautier, E.L., Ivanov, S., Satpathy, A.T., Schilling, J.D., Schwendener, R., Sergin, I., Razani, B., Forsberg, E.C., Yokoyama, W.M., Unanue, E.R., Colonna, M., Randolph, G.J., Mann, D.L., Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40:1 (2014), 91–104.
158. Hamilton, J.A., Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8:7 (2008), 533–544.
159. Christ, A., Bekkering, S., Latz, E., Riksen, N.P., Long-term activation of the innate immune system in atherosclerosis. Semin. Immunol. 28:4 (2016), 384–393.
160. Fairweather, D., Frisancho-Kiss, S., Yusung, S.A., Barrett, M.A., Davis, S.E., Steele, R.A., Gatewood, S.J.L., Rose, N.R., IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J. Immunol. 174:1 (2005), 261–269.
161. Godwin, J.W., Pinto, A.R., Rosenthal, N.A., Chasing the recipe for a pro-regenerative immune system. Semin. Cell Dev. Biol. 61 (2017), 71–79.
162. Delarosa, O., Dalemans, W., Lombardo, E., Toll-like receptors as modulators of mesenchymal stem cells. Front. Immunol., 3, 2012, 182.
163. Yilmaz, A., Dietel, B., Cicha, I., Schubert, K., Hausmann, R., Daniel, W.G., Garlichs, C.D., Stumpf, C., Emergence of dendritic cells in the myocardium after acute myocardial infarction - implications for inflammatory myocardial damage. Int. J. Biomed. Sci. IJBS 6:1 (2010), 27–36.
164. Mauri, C., Bosma, A., Immune regulatory function of B cells. Annu. Rev. Immunol. 30 (2012), 221–241.
165. Franquesa, M., Mensah, F.K., Huizinga, R., Strini, T., Boon, L., Lombardo, E., DelaRosa, O., Laman, J.D., Grinyó, J.M., Weimar, W., Betjes, M.G.H., Baan, C.C., Hoogduijn, M.J., Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells. Stem Cells 33:3 (2015), 880–891.
166. Yan, X., Anzai, A., Katsumata, Y., Matsuhashi, T., Ito, K., Endo, J., Yamamoto, T., Takeshima, A., Shinmura, K., Shen, W., Fukuda, K., Sano, M., Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J. Mol. Cell. Cardiol. 62 (2013), 24–35.
167. King, K.Y., Goodell, M.A., Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat. Rev. Immunol. 11:10 (2011), 685–692.
168. Esplin, B.L., Shimazu, T., Welner, R.S., Garrett, K.P., Nie, L., Zhang, Q., Humphrey, M.B., Yang, Q., Borghesi, L.A., Kincade, P.W., Chronic exposure to a TLR ligand injures hematopoietic stem cells. J. Immunol. 186:9 (2011), 5367–5375.
169. Winkler, I.G., Sims, N.A., Pettit, A.R., Barbier, V., Nowlan, B., Helwani, F., Poulton, I.J., van Rooijen, N., Alexander, K.A., Raggatt, L.J., Lévesque, J.-P., Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 116:23 (2010), 4815–4828.
170. Ii, M., Nishimura, H., Iwakura, A., Wecker, A., Eaton, E., Asahara, T., Losordo, D.W., Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via “imported” nitric oxide synthase activity. Circulation 111:9 (2005), 1114–1120.
171. Bogdan, C., Nitric oxide and the immune response. Nat. Immunol. 2:10 (2001), 907–916.
172. Bleul, C.C., Fuhlbrigge, R.C., Casasnovas, J.M., Aiuti, A., Springer, T.A., A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184:3 (1996), 1101–1109.
173. Wan, X., Xia, W., Gendoo, Y., Chen, W., Sun, W., Sun, D., Cao, C., Upregulation of stromal cell-derived factor 1 (SDF-1) is associated with macrophage infiltration in renal ischemia-reperfusion injury. PLoS One, 9(12), 2014, e114564.
174. Smith, T.J., Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?. Pharmacol. Rev. 62:2 (2010), 199–236.
175. Matysiak, M., Orlowski, W., Fortak-Michalska, M., Jurewicz, A., Selmaj, K., Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2. J. Neuroimmunol. 233:1–2 (2011), 106–111.
176. Su, J., Chen, X., Huang, Y., Li, W., Li, J., Cao, K., Cao, G., Zhang, L., Li, F., Roberts, A.I., Kang, H., Yu, P., Ren, G., Ji, W., Wang, Y., Shi, Y., Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species. Cell Death Differ. 21:3 (2014), 388–396.
177. Selmani, Z., Naji, A., Zidi, I., Favier, B., Gaiffe, E., Obert, L., Borg, C., Saas, P., Tiberghien, P., Rouas-Freiss, N., Carosella, E.D., Deschaseaux, F., Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4 + CD25highFOXP3 + regulatory T cells. Stem Cells 26:1 (2008), 212–222.
178. Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G.L., Pistoia, V., Uccelli, A., Human mesenchymal stem cells modulate B-cell functions. Blood 107:1 (2006), 367–372.
179. Rafei, M., Hsieh, J., Fortier, S., Li, M., Yuan, S., Birman, E., Forner, K., Boivin, M.-N., Doody, K., Tremblay, M., Annabi, B., Galipeau, J., Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. Blood 112:13 (2008), 4991–4998.
180. Schena, F., Gambini, C., Gregorio, A., Mosconi, M., Reverberi, D., Gattorno, M., Casazza, S., Uccelli, A., Moretta, L., Martini, A., Traggiai, E., Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis Rheum. 62:9 (2010), 2776–2786.
181. Spaggiari, G.M., Abdelrazik, H., Becchetti, F., Moretta, L., MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113:26 (2009), 6576–6583.
182. Liu, X., Qu, X., Chen, Y., Liao, L., Cheng, K., Shao, C., Zenke, M., Keating, A., Zhao, R.C.H., Mesenchymal stem/stromal cells induce the generation of novel IL-10-dependent regulatory dendritic cells by SOCS3 activation. J. Immunol. 189:3 (2012), 1182–1192.
183. Sotiropoulou, P.A., Perez, S.A., Gritzapis, A.D., Baxevanis, C.N., Papamichail, M., Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24:1 (2006), 74–85.
184. Spaggiari, G.M., Capobianco, A., Abdelrazik, H., Becchetti, F., Mingari, M.C., Moretta, L., Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111:3 (2008), 1327–1333.
185. Rashedi, I., Gómez-Aristizábal, A., Wang, X.-H., Viswanathan, S., Keating, A., TLR3 or TLR4 activation enhances mesenchymal stromal cell-mediated Treg induction via notch signaling. Stem Cells 35:1 (2017), 265–275.
186. Cole, J.E., Navin, T.J., Cross, A.J., Goddard, M.E., Alexopoulou, L., Mitra, A.T., Davies, A.H., Flavell, R.A., Feldmann, M., Monaco, C., Unexpected protective role for toll-like receptor 3 in the arterial wall. Proc. Natl. Acad. Sci. U. S. A. 108:6 (2011), 2372–2377.
187. Pan, L.-n., Zhu, W., Li, Y., Xu, X.-l., Guo, L.-j., Lu, Q., Wang, J., Astrocytic toll-like receptor 3 is associated with ischemic preconditioning-induced protection against brain ischemia in rodents. PLoS One, 9(6), 2014, e99526.
188. Li, Y., Xu, X.-l., Zhao, D., Pan, L.-n., Huang, C.-W., Guo, L.-j., Lu, Q., Wang, J., TLR3 ligand poly IC attenuates reactive astrogliosis and improves recovery of rats after focal cerebral ischemia. CNS Neurosci. Ther. 21:11 (2015), 905–913.
189. Németh, K., Leelahavanichkul, A., Yuen, P.S.T., Mayer, B., Parmelee, A., Doi, K., Robey, P.G., Leelahavanichkul, K., Koller, B.H., Brown, J.M., Hu, X., Jelinek, I., Star, R.A., Mezey, E., Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15:1 (2009), 42–49.
190. Carlson, S., Trial, J., Soeller, C., Entman, M.L., Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction. Cardiovasc. Res. 91:1 (2011), 99–107.
191. Cieslik, K.A., Taffet, G.E., Carlson, S., Hermosillo, J., Trial, J., Entman, M.L., Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heart. J. Mol. Cell. Cardiol. 50:1 (2011), 248–256.
192. Miragoli, M., Salvarani, N., Rohr, S., Myofibroblasts induce ectopic activity in cardiac tissue. Circ. Res. 101:8 (2007), 755–758.
193. Toma, C., Pittenger, M.F., Cahill, K.S., Byrne, B.J., Kessler, P.D., Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105:1 (2002), 93–98.
194. Rota, M., Kajstura, J., Hosoda, T., Bearzi, C., Vitale, S., Esposito, G., Iaffaldano, G., Padin-Iruegas, M.E., Gonzalez, A., Rizzi, R., Small, N., Muraski, J., Alvarez, R., Chen, X., Urbanek, K., Bolli, R., Houser, S.R., Leri, A., Sussman, M.A., Anversa, P., Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc. Natl. Acad. Sci. U. S. A. 104:45 (2007), 17783–17788.
195. Kajstura, J., Rota, M., Whang, B., Cascapera, S., Hosoda, T., Bearzi, C., Nurzynska, D., Kasahara, H., Zias, E., Bonafe, M., Nadal-Ginard, B., Torella, D., Nascimbene, A., Quaini, F., Urbanek, K., Leri, A., Anversa, P., Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ. Res. 96:1 (2005), 127–137.
196. Murasawa, S., Kawamoto, A., Horii, M., Nakamori, S., Asahara, T., Niche-dependent translineage commitment of endothelial progenitor cells, not cell fusion in general, into myocardial lineage cells. Arterioscler. Thromb. Vasc. Biol. 25:7 (2005), 1388–1394.
197. Yoon, Y.-s., Wecker, A., Heyd, L., Park, J.-S., Tkebuchava, T., Kusano, K., Hanley, A., Scadova, H., Qin, G., Cha, D.-H., Johnson, K.L., Aikawa, R., Asahara, T., Losordo, D.W., Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 115:2 (2005), 326–338.
198. Murry, C.E., Soonpaa, M.H., Reinecke, H., Nakajima, H., Nakajima, H.O., Rubart, M., Pasumarthi, K.B.S., Virag, J.I., Bartelmez, S.H., Poppa, V., Bradford, G., Dowell, J.D., Williams, D.A., Field, L.J., Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:6983 (2004), 664–668.
199. Balsam, L.B., Wagers, A.J., Christensen, J.L., Kofidis, T., Weissman, I.L., Robbins, R.C., Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428:6983 (2004), 668–673.
200. Yoshioka, T., Ageyama, N., Shibata, H., Yasu, T., Misawa, Y., Takeuchi, K., Matsui, K., Yamamoto, K., Terao, K., Shimada, K., Ikeda, U., Ozawa, K., Hanazono, Y., Repair of infarcted myocardium mediated by transplanted bone marrow-derived CD34 + stem cells in a nonhuman primate model. Stem Cells 23:3 (2005), 355–364.
201. Nygren, J.M., Jovinge, S., Breitbach, M., Sawen, P., Roll, W., Hescheler, J., Taneera, J., Fleischmann, B.K., Jacobsen, S.E.W., Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10:5 (2004), 494–501.
202. Andrade, J., Lam, J.T., Zamora, M., Huang, C., Franco, D., Sevilla, N., Gruber, P.J., Lu, J.T., Ruiz-Lozano, P., Predominant fusion of bone marrow-derived cardiomyocytes. Cardiovasc. Res. 68:3 (2005), 387–393.
203. Alvarez-Dolado, M., Pardal, R., Garcia-Verdugo, J.M., Fike, J.R., Lee, H.O., Pfeffer, K., Lois, C., Morrison, S.J., Alvarez-Buylla, A., Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425:6961 (2003), 968–973.
204. Zhang, S., Wang, D., Estrov, Z., Raj, S., Willerson, J.T., Yeh, E.T.H., Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation 110:25 (2004), 3803–3807.
205. Iwasaki, H., Kawamoto, A., Ishikawa, M., Oyamada, A., Nakamori, S., Nishimura, H., Sadamoto, K., Horii, M., Matsumoto, T., Murasawa, S., Shibata, T., Suehiro, S., Asahara, T., Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 113:10 (2006), 1311–1325.
206. Yeh, E.T.H., Zhang, S., Wu, H.D., Korbling, M., Willerson, J.T., Estrov, Z., Transdifferentiation of human peripheral blood CD34 +-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108:17 (2003), 2070–2073.
207. Bai, X., Yan, Y., Song, Y.-H., Seidensticker, M., Rabinovich, B., Metzele, R., Bankson, J.A., Vykoukal, D., Alt, E., Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur. Heart J. 31:4 (2010), 489–501.
208. Zhang, S., Shpall, E., Willerson, J.T., Yeh, E.T.H., Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction. Circ. Res. 100:5 (2007), 693–702.
209. Acquistapace, A., Bru, T., Lesault, P.-F., Figeac, F., Coudert, A.E., Le Coz, O., Christov, C., Baudin, X., Auber, F., Yiou, R., Dubois-Rande, J.-L., Rodriguez, A.-M., Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cells 29:5 (2011), 812–824.
210. Wang, L., Deng, J., Tian, W., Xiang, B., Yang, T., Li, G., Wang, J., Gruwel, M., Kashour, T., Rendell, J., Glogowski, M., Tomanek, B., Freed, D., Deslauriers, R., Arora, R.C., Tian, G., Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. Am. J. Physiol. Heart Circ. Physiol. 297:3 (2009), H1020–31.
211. Zeng, L., Hu, Q., Wang, X., Mansoor, A., Lee, J., Feygin, J., Zhang, G., Suntharalingam, P., Boozer, S., Mhashilkar, A., Panetta, C.J., Swingen, C., Deans, R., From, A.H.L., Bache, R.J., Verfaillie, C.M., Zhang, J., Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation 115:14 (2007), 1866–1875.
212. Tang, X.-L., Li, Q., Rokosh, G., Sanganalmath, S.K., Chen, N., Ou, Q., Stowers, H., Hunt, G., Bolli, R., Long-term outcome of administration of c-kit(POS) cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, but structural and functional improvement and proliferation of endogenous cells persist for at least one year. Circ. Res. 118:7 (2016), 1091–1105.
213. Hong, K.U., Li, Q.-H., Guo, Y., Patton, N.S., Moktar, A., Bhatnagar, A., Bolli, R., A highly sensitive and accurate method to quantify absolute numbers of c-kit + cardiac stem cells following transplantation in mice. Basic Res. Cardiol., 108(3), 2013, 346.
214. Penicka, M., Widimsky, P., Kobylka, P., Kozak, T., Lang, O., Images in cardiovascular medicine. Early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction. Circulation 112:4 (2005), e63–5.
215. Smith, R.R., Barile, L., Cho, H.C., Leppo, M.K., Hare, J.M., Messina, E., Giacomello, A., Abraham, M.R., Marban, E., Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115:7 (2007), 896–908.
216. Dawn, B., Stein, A.B., Urbanek, K., Rota, M., Whang, B., Rastaldo, R., Torella, D., Tang, X.-L., Rezazadeh, A., Kajstura, J., Leri, A., Hunt, G., Varma, J., Prabhu, S.D., Anversa, P., Bolli, R., Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc. Natl. Acad. Sci. U. S. A. 102:10 (2005), 3766–3771.
217. Smits, A.M., van Laake, L.W., den Ouden, K., Schreurs, C., Szuhai, K., van Echteld, C.J., Mummery, C.L., Doevendans, P.A., Goumans, M.-J., Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc. Res. 83:3 (2009), 527–535.
218. D'Alessandro, D.A., Kajstura, J., Hosoda, T., Gatti, A., Bello, R., Mosna, F., Bardelli, S., Zheng, H., D'Amario, D., Padin-Iruegas, M.E., Carvalho, A.B., Rota, M., Zembala, M.O., Stern, D., Rimoldi, O., Urbanek, K., Michler, R.E., Leri, A., Anversa, P., Progenitor cells from the explanted heart generate immunocompatible myocardium within the transplanted donor heart. Circ. Res. 105:11 (2009), 1128–1140.
219. Rota, M., Padin-Iruegas, M.E., Misao, Y., de Angelis, A., Maestroni, S., Ferreira-Martins, J., Fiumana, E., Rastaldo, R., Arcarese, M.L., Mitchell, T.S., Boni, A., Bolli, R., Urbanek, K., Hosoda, T., Anversa, P., Leri, A., Kajstura, J., Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ. Res. 103:1 (2008), 107–116.
220. Tang, X.-L., Rokosh, G., Sanganalmath, S.K., Yuan, F., Sato, H., Mu, J., Dai, S., Li, C., Chen, N., Peng, Y., Dawn, B., Hunt, G., Leri, A., Kajstura, J., Tiwari, S., Shirk, G., Anversa, P., Bolli, R., Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 121:2 (2010), 293–305.
221. van Berlo, J.H., Kanisicak, O., Maillet, M., Vagnozzi, R.J., Karch, J., Lin, S.-C.J., Middleton, R.C., Marban, E., Molkentin, J.D., c-kit + cells minimally contribute cardiomyocytes to the heart. Nature 509:7500 (2014), 337–341.
222. Sultana, N., Zhang, L., Yan, J., Chen, J., Cai, W., Razzaque, S., Jeong, D., Sheng, W., Bu, L., Xu, M., Huang, G.-Y., Hajjar, R.J., Zhou, B., Moon, A., Cai, C.-L., Resident c-kit(+) cells in the heart are not cardiac stem cells. Nat. Commun., 6, 2015, 8701.
223. Liu, Q., Yang, R., Huang, X., Zhang, H., He, L., Zhang, L., Tian, X., Nie, Y., Hu, S., Yan, Y., Zhang, L., Qiao, Z., Wang, Q.-D., Lui, K.O., Zhou, B., Genetic lineage tracing identifies in situ Kit-expressing cardiomyocytes. Cell Res. 26:1 (2016), 119–130.
224. Bergmann, O., Bhardwaj, R.D., Bernard, S., Zdunek, S., Barnabe-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B.A., Druid, H., Jovinge, S., Frisen, J., Evidence for cardiomyocyte renewal in humans. Science (New York, N.Y.) 324:5923 (2009), 98–102.
225. Kajstura, J., Urbanek, K., Perl, S., Hosoda, T., Zheng, H., Ogorek, B., Ferreira-Martins, J., Goichberg, P., Rondon-Clavo, C., Sanada, F., D'Amario, D., Rota, M., Del Monte, F., Orlic, D., Tisdale, J., Leri, A., Anversa, P., Cardiomyogenesis in the adult human heart. Circ. Res. 107:2 (2010), 305–315.
226. Zwetsloot, P.P., Vegh, A.M.D., Jansen of Lorkeers, S.J., van Hout, G.P.J., Currie, G.L., Sena, E.S., Gremmels, H., Buikema, J.W., Goumans, M.-J., Macleod, M.R., Doevendans, P.A., Chamuleau, S.A.J., Sluijter, J.P.G., Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies. Circ. Res. 118:8 (2016), 1223–1232.
227. Lang, C.I., Wolfien, M., Langenbach, A., Müller, P., Wolkenhauer, O., Yavari, A., Ince, H., Steinhoff, G., Krause, B.J., David, R., Glass, Ä., Cardiac cell therapies for the treatment of acute myocardial infarction: a meta-analysis from mouse studies. Cell. Physiol. Biochem. 42:1 (2017), 254–268.
228. Bolli, R., Chugh, A.R., D'Amario, D., Loughran, J.H., Stoddard, M.F., Ikram, S., Beache, G.M., Wagner, S.G., Leri, A., Hosoda, T., Sanada, F., Elmore, J.B., Goichberg, P., Cappetta, D., Solankhi, N.K., Fahsah, I., Rokosh, D.G., Slaughter, M.S., Kajstura, J., Anversa, P., Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378:9806 (2011), 1847–1857.
229. Chugh, A.R., Beache, G.M., Loughran, J.H., Mewton, N., Elmore, J.B., Kajstura, J., Pappas, P., Tatooles, A., Stoddard, M.F., Lima, J.A.C., Slaughter, M.S., Anversa, P., Bolli, R., Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 126:11 Suppl 1 (2012), S54–64.
230. Malliaras, K., Makkar, R.R., Smith, R.R., Cheng, K., Wu, E., Bonow, R.O., Marban, L., Mendizabal, A., Cingolani, E., Johnston, P.V., Gerstenblith, G., Schuleri, K.H., Lardo, A.C., Marban, E., Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-derived aUtologous stem CElls to reverse ventricUlar dySfunction). J. Am. Coll. Cardiol. 63:2 (2014), 110–122.
231. Dimmeler, S., Zeiher, A.M., Cell therapy of acute myocardial infarction: open questions. Cardiology 113:3 (2009), 155–160.
232. Strauer, B.E., Brehm, M., Zeus, T., Gattermann, N., Hernandez, A., Sorg, R.V., Kogler, G., Wernet, P., Intrakoronare, humane autologe Stammzelltransplantation zur Myokardregeneration nach Herzinfarkt. Dtsch. Med. Wschr. 126:34–35 (2001), 932–938.
233. Choudhury, T., Mozid, A., Hamshere, S., Yeo, C., Pellaton, C., Arnous, S., Saunders, N., Brookman, P., Jain, A., Locca, D., Archbold, A., Knight, C., Wragg, A., Davies, C., Mills, P., Parmar, M., Rothman, M., Choudry, F., Jones, D.A., Agrawal, S., Martin, J., Mathur, A., An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial. Eur. J. Heart Fail. 19:1 (2017), 138–147.
234. Schachinger, V., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., Holschermann, H., Yu, J., Corti, R., Mathey, D.G., Hamm, C.W., Suselbeck, T., Assmus, B., Tonn, T., Dimmeler, S., Zeiher, A.M., Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355:12 (2006), 1210–1221.
235. Wollert, K.C., Meyer, G.P., Lotz, J., Ringes Lichtenberg, S., Lippolt, P., Breidenbach, C., Fichtner, S., Korte, T., Hornig, B., Messinger, D., Arseniev, L., Hertenstein, B., Ganser, A., Drexler, H., Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364:9429 (2004), 141–148.
236. Huikuri, H.V., Kervinen, K., Niemela, M., Ylitalo, K., Saily, M., Koistinen, P., Savolainen, E.-R., Ukkonen, H., Pietila, M., Airaksinen, J.K.E., Knuuti, J., Makikallio, T.H., Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur. Heart J. 29:22 (2008), 2723–2732.
237. Assmus, B., Walter, D.H., Seeger, F.H., Leistner, D.M., Steiner, J., Ziegler, I., Lutz, A., Khaled, W., Klotsche, J., Tonn, T., Dimmeler, S., Zeiher, A.M., Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial. JAMA 309:15 (2013), 1622–1631.
238. Pokushalov, E., Romanov, A., Chernyavsky, A., Larionov, P., Terekhov, I., Artyomenko, S., Poveshenko, O., Kliver, E., Shirokova, N., Karaskov, A., Dib, N., Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study. J. Cardiovasc. Transl. Res. 3:2 (2010), 160–168.
239. Zhao, Q., Sun, Y., Xia, L., Chen, A., Wang, Z., Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. Ann. Thorac. Surg. 86:6 (2008), 1833–1840.
240. Hu, S., Liu, S., Zheng, Z., Yuan, X., Li, L., Lu, M., Shen, R., Duan, F., Zhang, X., Li, J., Liu, X., Song, Y., Wang, W., Zhao, S., He, Z., Zhang, H., Yang, K., Feng, W., Wang, X., Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: a single-center, randomized, double-blind, placebo-controlled clinical trial. J. Am. Coll. Cardiol. 57:24 (2011), 2409–2415.
241. Lu, M., Liu, S., Zheng, Z., Yin, G., Song, L., Chen, H., Chen, X., Chen, Q., Jiang, S., Tian, L., He, Z., Hu, S., Zhao, S., A pilot trial of autologous bone marrow mononuclear cell transplantation through grafting artery: a sub-study focused on segmental left ventricular function recovery and scar reduction. Int. J. Cardiol. 168:3 (2013), 2221–2227.
242. Traverse, J.H., Henry, T.D., Ellis, S.G., Pepine, C.J., Willerson, J.T., Zhao, D.X.M., Forder, J.R., Byrne, B.J., Hatzopoulos, A.K., Penn, M.S., Perin, E.C., Baran, K.W., Chambers, J., Lambert, C., Raveendran, G., Simon, D.I., Vaughan, D.E., Simpson, L.M., Gee, A.P., Taylor, D.A., Cogle, C.R., Thomas, J.D., Silva, G.V., Jorgenson, B.C., Olson, R.E., Bowman, S., Francescon, J., Geither, C., Handberg, E., Smith, D.X., Baraniuk, S., Piller, L.B., Loghin, C., Aguilar, D., Richman, S., Zierold, C., Bettencourt, J., Sayre, S.L., Vojvodic, R.W., Skarlatos, S.I., Gordon, D.J., Ebert, R.F., Kwak, M., Moye, L.A., Simari, R.D., Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA 306:19 (2011), 2110–2119.
243. Perin, E.C., Willerson, J.T., Pepine, C.J., Henry, T.D., Ellis, S.G., Zhao, D.X.M., Silva, G.V., Lai, D., Thomas, J.D., Kronenberg, M.W., Martin, A.D., Anderson, R.D., Traverse, J.H., Penn, M.S., Anwaruddin, S., Hatzopoulos, A.K., Gee, A.P., Taylor, D.A., Cogle, C.R., Smith, D., Westbrook, L., Chen, J., Handberg, E., Olson, R.E., Geither, C., Bowman, S., Francescon, J., Baraniuk, S., Piller, L.B., Simpson, L.M., Loghin, C., Aguilar, D., Richman, S., Zierold, C., Bettencourt, J., Sayre, S.L., Vojvodic, R.W., Skarlatos, S.I., Gordon, D.J., Ebert, R.F., Kwak, M., Moye, L.A., Simari, R.D., Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 307:16 (2012), 1717–1726.
244. Patila, T., Lehtinen, M., Vento, A., Schildt, J., Sinisalo, J., Laine, M., Hammainen, P., Nihtinen, A., Alitalo, R., Nikkinen, P., Ahonen, A., Holmstrom, M., Lauerma, K., Poyhia, R., Kupari, M., Kankuri, E., Harjula, A., Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: a prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass. J Heart Lung Transplant 33:6 (2014), 567–574.
245. Sant'Anna, R.T., Fracasso, J., Valle, F.H., Castro, I., Nardi, N.B., Sant'Anna, J.R.M., Nesralla, I.A., Kalil, R.A.K., Direct intramyocardial transthoracic transplantation of bone marrow mononuclear cells for non-ischemic dilated cardiomyopathy: INTRACELL, a prospective randomized controlled trial. Rev. Bras. Cir. Cardiovasc. 29:3 (2014), 437–447.
246. Ang, K.-L., Chin, D., Leyva, F., Foley, P., Kubal, C., Chalil, S., Srinivasan, L., Bernhardt, L., Stevens, S., Shenje, L.T., Galinanes, M., Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nat. Clin. Pract. Cardiovasc. Med. 5:10 (2008), 663–670.
247. Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., Egeland, T., Endresen, K., Ilebekk, A., Mangschau, A., Fjeld, J.G., Smith, H.J., Taraldsrud, E., Grogaard, H.K., Bjornerheim, R., Brekke, M., Muller, C., Hopp, E., Ragnarsson, A., Brinchmann, J.E., Forfang, K., Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355:12 (2006), 1199–1209.
248. Hirsch, A., Nijveldt, R., van der Vleuten, P.A., Tijssen, J.G.P., van der Giessen, W.J., Tio, R.A., Waltenberger, J., ten Berg, J.M., Doevendans, P.A., Aengevaeren, W.R.M., Zwaginga, J.J., Biemond, B.J., van Rossum, A.C., Piek, J.J., Zijlstra, F., Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur. Heart J. 32:14 (2011), 1736–1747.
249. Surder, D., Manka, R., Lo Cicero, V., Moccetti, T., Rufibach, K., Soncin, S., Turchetto, L., Radrizzani, M., Astori, G., Schwitter, J., Erne, P., Zuber, M., Auf der Maur, C., Jamshidi, P., Gaemperli, O., Windecker, S., Moschovitis, A., Wahl, A., Buhler, I., Wyss, C., Kozerke, S., Landmesser, U., Luscher, T.F., Corti, R., Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function. Circulation 127:19 (2013), 1968–1979.
250. Heldman, A.W., DiFede, D.L., Fishman, J.E., Zambrano, J.P., Trachtenberg, B.H., Karantalis, V., Mushtaq, M., Williams, A.R., Suncion, V.Y., McNiece, I.K., Ghersin, E., Soto, V., Lopera, G., Miki, R., Willens, H., Hendel, R., Mitrani, R., Pattany, P., Feigenbaum, G., Oskouei, B., Byrnes, J., Lowery, M.H., Sierra, J., Pujol, M.V., Delgado, C., Gonzalez, P.J., Rodriguez, J.E., Bagno, L.L., Rouy, D., Altman, P., Foo, C.W.P., Da Silva, J., Anderson, E., Schwarz, R., Mendizabal, A., Hare, J.M., Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA 311:1 (2014), 62–73.
251. Santoso, T., Siu, C.-W., Irawan, C., Chan, W.-S., Alwi, I., Yiu, K.-H., Aziz, A., Kwong, Y.-L., Tse, H.-F., Endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure: a randomized placebo-controlled trial (END-HF). J. Cardiovasc. Transl. Res. 7:6 (2014), 545–552.
252. Sadat, K., Ather, S., Aljaroudi, W., Heo, J., Iskandrian, A.E., Hage, F.G., The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion. J. Nucl. Cardiol. 21:2 (2014), 351–367.
253. Wen, Y., Chen, B., Wang, C., Ma, X., Gao, Q., Bone marrow-derived mononuclear cell therapy for patients with ischemic heart disease and ischemic heart failure. Expert. Opin. Biol. Ther. 12:12 (2012), 1563–1573.
254. Ye, Z., Zhang, B.-L., Zhao, X.-X., Qin, Y.-W., Wu, H., Cao, J., Zhang, J.-L., Hu, J.-Q., Zheng, X., Xu, R.-L., Intracoronary infusion of bone marrow-derived mononuclear cells contributes to longstanding improvements of left ventricular performance and remodelling after acute myocardial infarction: a meta-analysis. Heart Lung Circ. 21:11 (2012), 725–733.
255. de Jong, R., Houtgraaf, J.H., Samiei, S., Boersma, E., Duckers, H.J., Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials. Circ. Cardiovasc. Interv. 7:2 (2014), 156–167.
256. Jeevanantham, V., Butler, M., Saad, A., Abdel-Latif, A., Zuba-Surma, E.K., Dawn, B., Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 126:5 (2012), 551–568.
257. Traverse, J.H., Henry, T.D., Moye, L.A., Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging. Am. Heart J. 162:4 (2011), 671–677.
258. Sheridan, W.P., Begley, C.G., Juttner, C.A., Szer, J., To, L.B., Maher, D., McGrath, K.M., Morstyn, G., Fox, R.M., Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:8794 (1992), 640–644.
259. Moazzami, K., Roohi, A., Moazzami, B., Granulocyte colony stimulating factor therapy for acute myocardial infarction. Cochrane Database Syst. Rev.(5), 2013, CD008844.
260. Zohlnhofer, D., Dibra, A., Koppara, T., de Waha, A., Ripa, R.S., Kastrup, J., Valgimigli, M., Schomig, A., Kastrati, A., Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. J. Am. Coll. Cardiol. 51:15 (2008), 1429–1437.
261. Abdel-Latif, A., Bolli, R., Zuba-Surma, E.K., Tleyjeh, I.M., Hornung, C.A., Dawn, B., Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am. Heart J. 156:2 (2008), 216–226 (.e9).
262. Kang, H.-J., Kim, H.-S., Zhang, S.-Y., Park, K.-W., Cho, H.-J., Koo, B.-K., Kim, Y.-J., Lee, D.S., Sohn, D.-W., Han, K.-S., Oh, B.-H., Lee, M.-M., Park, Y.-B., Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363:9411 (2004), 751–756.
263. Kang, H.-J., Lee, H.-Y., Na, S.-H., Chang, S.-A., Park, K.-W., Kim, H.-K., Kim, S.-Y., Chang, H.-J., Lee, W., Kang, W.J., Koo, B.-K., Kim, Y.-J., Lee, D.S., Sohn, D.-W., Han, K.-S., Oh, B.-H., Park, Y.-B., Kim, H.-S., Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 114:1 Suppl (2006), I145–51.
264. Li, Z.-q., Zhang, M., Jing, Y.-z., Zhang, W.-w., Liu, Y., Cui, L.-j., Yuan, L., Liu, X.-z., Yu, X., Hu, T.-s., The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). Int. J. Cardiol. 115:1 (2007), 52–56.
265. Tatsumi, T., Ashihara, E., Yasui, T., Matsunaga, S., Kido, A., Sasada, Y., Nishikawa, S., Hadase, M., Koide, M., Nakamura, R., Irie, H., Ito, K., Matsui, A., Matsui, H., Katamura, M., Kusuoka, S., Matoba, S., Okayama, S., Horii, M., Uemura, S., Shimazaki, C., Tsuji, H., Saito, Y., Matsubara, H., Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circ. J. 71:8 (2007), 1199–1207.
266. Vrtovec, B., Sever, M., Jensterle, M., Poglajen, G., Janez, A., Kravos, N., Zemljic, G., Cukjati, M., Cernelc, P., Haddad, F., Wu, J.C., Jorde, U.P., Efficacy of CD34 + stem cell therapy in nonischemic dilated cardiomyopathy is absent in patients with diabetes but preserved in patients with insulin resistance. Stem Cells Transl. Med. 5:5 (2016), 632–638.
267. Lezaic, L., Socan, A., Poglajen, G., Peitl, P.K., Sever, M., Cukjati, M., Cernelc, P., Wu, J.C., Haddad, F., Vrtovec, B., Intracoronary transplantation of CD34(+) cells is associated with improved myocardial perfusion in patients with nonischemic dilated cardiomyopathy. J. Card. Fail. 21:2 (2015), 145–152.
268. Poglajen, G., Sever, M., Cukjati, M., Cernelc, P., Knezevic, I., Zemljic, G., Haddad, F., Wu, J.C., Vrtovec, B., Effects of transendocardial CD34 + cell transplantation in patients with ischemic cardiomyopathy. Circ. Cardiovasc. Interv. 7:4 (2014), 552–559.
269. Losordo, D.W., Henry, T.D., Davidson, C., Sup Lee, J., Costa, M.A., Bass, T., Mendelsohn, F., Fortuin, F.D., Pepine, C.J., Traverse, J.H., Amrani, D., Ewenstein, B.M., Riedel, N., Story, K., Barker, K., Povsic, T.J., Harrington, R.A., Schatz, R.A., Intramyocardial, autologous CD34 + cell therapy for refractory angina. Circ. Res. 109:4 (2011), 428–436.
270. Kawamoto, A., Iwasaki, H., Kusano, K., Murayama, T., Oyamada, A., Silver, M., Hulbert, C., Gavin, M., Hanley, A., Ma, H., Kearney, M., Zak, V., Asahara, T., Losordo, D.W., CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 114:20 (2006), 2163–2169.
271. Vrtovec, B., Poglajen, G., Lezaic, L., Sever, M., Socan, A., Domanovic, D., Cernelc, P., Torre-Amione, G., Haddad, F., Wu, J.C., Comparison of transendocardial and intracoronary CD34 + cell transplantation in patients with nonischemic dilated cardiomyopathy. Circulation 128:11 Suppl 1 (2013), S42–9.
272. Vrtovec, B., Poglajen, G., Lezaic, L., Sever, M., Domanovic, D., Cernelc, P., Socan, A., Schrepfer, S., Torre-Amione, G., Haddad, F., Wu, J.C., Effects of intracoronary CD34 + stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ. Res. 112:1 (2013), 165–173.
273. Pasquet, S., Sovalat, H., Henon, P., Bischoff, N., Arkam, Y., Ojeda-Uribe, M., Le Bouar, R., Rimelen, V., Brink, I., Dallemand, R., Monassier, J.-P., Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34 + cells containing cardiac progenitors on regional heart structure and function after myocardial infarct. Cytotherapy 11:8 (2009), 1002–1015.
274. Lee, F.-Y., Chen, Y.-L., Sung, P.-H., Ma, M.-C., Pei, S.-N., Wu, C.-J., Yang, C.-H., Fu, M., Ko, S.-F., Leu, S., Yip, H.-K., Intracoronary transfusion of circulation-derived CD34 + cells improves left ventricular function in patients with end-stage diffuse coronary artery disease unsuitable for coronary intervention. Crit. Care Med. 43:10 (2015), 2117–2132.
275. Povsic, T.J., Henry, T.D., Traverse, J.H., Fortuin, F.D., Schaer, G.L., Kereiakes, D.J., Schatz, R.A., Zeiher, A.M., White, C.J., Stewart, D.J., Jolicoeur, E.M., Bass, T., Henderson, D.A., Dignacco, P., Gu, Z., Al-Khalidi, H.R., Junge, C., Nada, A., Hunt, A.S., Losordo, D.W., The RENEW trial: efficacy and safety of intramyocardial autologous CD34(+) cell administration in patients with refractory angina. JACC Cardiovasc. Interv. 9:15 (2016), 1576–1585.
276. Choi, J.-H., Choi, J., Lee, W.-S., Rhee, I., Lee, S.-C., Gwon, H.-C., Lee, S.H., Choe, Y.H., Kim, D.W., Suh, W., Kim, D.-K., Jeon, E.-S., Lack of additional benefit of intracoronary transplantation of autologous peripheral blood stem cell in patients with acute myocardial infarction. Circ. J. 71:4 (2007), 486–494.
277. Taylor, D.A., Perin, E.C., Willerson, J.T., Zierold, C., Resende, M., Carlson, M., Nestor, B., Wise, E., Orozco, A., Pepine, C.J., Henry, T.D., Ellis, S.G., Zhao, D.X.M., Traverse, J.H., Cooke, J.P., Schutt, R.C., Bhatnagar, A., Grant, M.B., Lai, D., Johnstone, B.H., Sayre, S.L., Moyé, L., Ebert, R.F., Bolli, R., Simari, R.D., Cogle, C.R., Identification of bone marrow cell subpopulations associated with improved functional outcomes in patients with chronic left ventricular dysfunction: an embedded cohort evaluation of the FOCUS-CCTRN trial. Cell Transplant. 25:9 (2016), 1675–1687.
278. Fernández-Avilés, F., Sanz-Ruiz, R., Climent, A.M., Badimon, L., Bolli, R., Charron, D., Fuster, V., Janssens, S., Kastrup, J., Kim, H.-S., Lüscher, T.F., Martin, J.F., Menasché, P., Simari, R.D., Stone, G.W., Terzic, A., Willerson, J.T., Wu, J.C., Global position paper on cardiovascular regenerative medicine: scientific statement of the transnational alliance for regenerative therapies in cardiovascular syndromes (TACTICS) international group for the comprehensive cardiovascular application of regenerative medicinal products. Eur. Heart J. 38:33 (2017), 2532–2546.
279. Patel, A.N., Geffner, L., Vina, R.F., Saslavsky, J., Urschel JR, H.C., Kormos, R., Benetti, F., Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J. Thorac. Cardiovasc. Surg. 130:6 (2005), 1631–1638.
280. Nasseri, B.A., Ebell, W., Dandel, M., Kukucka, M., Gebker, R., Doltra, A., Knosalla, C., Choi, Y.-H., Hetzer, R., Stamm, C., Autologous CD133 + bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial. Eur. Heart J. 35:19 (2014), 1263–1274.
281. Vakil, K., Florea, V., Koene, R., Kealhofer, J.V., Anand, I., Adabag, S., Effect of coronary artery bypass grafting on left ventricular ejection fraction in men eligible for implantable cardioverter-defibrillator. Am. J. Cardiol. 117:6 (2016), 957–960.
282. Sharma, A., Demissei, B.G., Tromp, J., Hillege, H.L., Cleland, J.G., O'Connor, C.M., Metra, M., Ponikowski, P., Teerlink, J.R., Davison, B.A., Givertz, M.M., Bloomfield, D.M., Dittrich, H., van Veldhuisen, D.J., Cotter, G., Ezekowitz, J.A., Khan, M.A.F., Voors, A.A., A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure. Eur. J. Heart Fail. 10 (2017), 1310–1320.
283. Chow, S.L., Maisel, A.S., Anand, I., Bozkurt, B., de Boer, R.A., Felker, G.M., Fonarow, G.C., Greenberg, B., Januzzi, J.L., Kiernan, M.S., Liu, P.P., Wang, T.J., Yancy, C.W., Zile, M.R., Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association. Circulation 135:22 (2017), e1054–e1091.
284. Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., Böhm, M., Nickenig, G., Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353:10 (2005), 999–1007.
285. Duckers, H.J., Silber, S., de Winter, R., den Heijer, P., Rensing, B., Rau, M., Mudra, H., Benit, E., Verheye, S., Wijns, W., Serruys, P.W., Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent. EuroIntervention 3:1 (2007), 67–75.
286. Aoki, J., Serruys, P.W., van Beusekom, H., Ong, A.T.L., McFadden, E.P., Sianos, G., van der Giessen, Willem J., Regar, E., de Feyter, P.J., Davis, H.R., Rowland, S., Kutryk, M.J.B., Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry. J. Am. Coll. Cardiol. 45:10 (2005), 1574–1579.
287. Real, C., Caiado, F., Dias, S., Endothelial progenitors in vascular repair and angiogenesis: how many are needed and what to do?. Cardiovasc. Hematol. Disord. Drug Targets 8:3 (2008), 185–193.
288. Low, A.F., Lee, C.-H., Teo, S.-G., Chan, M.Y., Tay, E., Lee, Y.-P., Chong, E., Co, M., Tin Hay, E., Lim, Y.-T., Tan, H.-C., Effectiveness and safety of the genous endothelial progenitor cell-capture stent in acute ST-elevation myocardial infarction. Am. J. Cardiol. 108:2 (2011), 202–205.
289. Silber, S., Damman, P., Klomp, M., Beijk, M.A., Grisold, M., Ribeiro, E.E., Suryapranata, H., Wójcik, J., Hian Sim, K., Tijssen, J.G.P., de Winter, R.J., Clinical results after coronary stenting with the Genous™ bio-engineered R stent™: 12-month outcomes of the e-HEALING (healthy endothelial accelerated lining inhibits neointimal growth) worldwide registry. EuroIntervention 6:7 (2011), 819–825.
290. Bhatnagar, A., Bolli, R., Johnstone, B.H., Traverse, J.H., Henry, T.D., Pepine, C.J., Willerson, J.T., Perin, E.C., Ellis, S.G., Zhao, D.X.M., Yang, P.C., Cooke, J.P., Schutt, R.C., Trachtenberg, B.H., Orozco, A., Resende, M., Ebert, R.F., Sayre, S.L., Simari, R.D., Moyé, L., Cogle, C.R., Taylor, D.A., Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-cardiovascular cell therapy research network (CCTRN) trial. Am. Heart J. 179 (2016), 142–150.
291. Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P.V., Mar, B.G., Lindsley, R.C., Mermel, C.H., Burtt, N., Chavez, A., Higgins, J.M., Moltchanov, V., Kuo, F.C., Kluk, M.J., Henderson, B., Kinnunen, L., Koistinen, H.A., Ladenvall, C., Getz, G., Correa, A., Banahan, B.F., Gabriel, S., Kathiresan, S., Stringham, H.M., McCarthy, M.I., Boehnke, M., Tuomilehto, J., Haiman, C., Groop, L., Atzmon, G., Wilson, J.G., Neuberg, D., Altshuler, D., Ebert, B.L., Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371:26 (2014), 2488–2498.
292. Jaiswal, S., Natarajan, P., Silver, A.J., Gibson, C.J., Bick, A.G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., Baber, U., Mehran, R., Fuster, V., Danesh, J., Frossard, P., Saleheen, D., Melander, O., Sukhova, G.K., Neuberg, D., Libby, P., Kathiresan, S., Ebert, B.L., Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N. Engl. J. Med. 377:2 (2017), 111–121.
293. Iversen, P.O., Woldbaek, P.R., Tønnessen, T., Christensen, G., Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282:1 (2002), R166–72.
294. Wellcome Trust Case Control Consortium, Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:7145 (2007), 661–678.
295. Lasho, T.L., Pardanani, A., Tefferi, A., LNK mutations in JAK2 mutation-negative erythrocytosis. N. Engl. J. Med. 363:12 (2010), 1189–1190.
296. Schunkert, H., König, I.R., Kathiresan, S., Reilly, M.P., Assimes, T.L., Holm, H., Preuss, M., Stewart, A.F.R., Barbalic, M., Gieger, C., Absher, D., Aherrahrou, Z., Allayee, H., Altshuler, D., Anand, S.S., Andersen, K., Anderson, J.L., Ardissino, D., Ball, S.G., Balmforth, A.J., Barnes, T.A., Becker, D.M., Becker, L.C., Berger, K., Bis, J.C., Boekholdt, S.M., Boerwinkle, E., Braund, P.S., Brown, M.J., Burnett, M.S., Buysschaert, I., Carlquist, J.F., Chen, L., Cichon, S., Codd, V., Davies, R.W., Dedoussis, G., Dehghan, A., Demissie, S., Devaney, J.M., Diemert, P., Do, R., Doering, A., Eifert, S., Mokhtari, N.E.E., Ellis, S.G., Elosua, R., Engert, J.C., Epstein, S.E., de Faire, U., Fischer, M., Folsom, A.R., Freyer, J., Gigante, B., Girelli, D., Gretarsdottir, S., Gudnason, V., Gulcher, J.R., Halperin, E., Hammond, N., Hazen, S.L., Hofman, A., Horne, B.D., Illig, T., Iribarren, C., Jones, G.T., Jukema, J.W., Kaiser, M.A., Kaplan, L.M., Kastelein, J.J.P., Khaw, K.-T., Knowles, J.W., Kolovou, G., Kong, A., Laaksonen, R., Lambrechts, D., Leander, K., Lettre, G., Li, M., Lieb, W., Loley, C., Lotery, A.J., Mannucci, P.M., Maouche, S., Martinelli, N., McKeown, P.P., Meisinger, C., Meitinger, T., Melander, O., Merlini, P.A., Mooser, V., Morgan, T., Mühleisen, T.W., Muhlestein, J.B., Münzel, T., Musunuru, K., Nahrstaedt, J., Nelson, C.P., Nöthen, M.M., Olivieri, O., Patel, R.S., Patterson, C.C., Peters, A., Peyvandi, F., Qu, L., Quyyumi, A.A., Rader, D.J., Rallidis, L.S., Rice, C., Rosendaal, F.R., Rubin, D., Salomaa, V., Sampietro, M.L., Sandhu, M.S., Schadt, E., Schäfer, A., Schillert, A., Schreiber, S., Schrezenmeir, J., Schwartz, S.M., Siscovick, D.S., Sivananthan, M., Sivapalaratnam, S., Smith, A., Smith, T.B., Snoep, J.D., Soranzo, N., Spertus, J.A., Stark, K., Stirrups, K., Stoll, M., Tang, W.H.W., Tennstedt, S., Thorgeirsson, G., Thorleifsson, G., Tomaszewski, M., Uitterlinden, A.G., van Rij, A.M., Voight, B.F., Wareham, N.J., Wells, G.A., Wichmann, H.-E., Wild, P.S., Willenborg, C., Witteman, J.C.M., Wright, B.J., Ye, S., Zeller, T., Ziegler, A., Cambien, F., Goodall, A.H., Cupples, L.A., Quertermous, T., März, W., Hengstenberg, C., Blankenberg, S., Ouwehand, W.H., Hall, A.S., Deloukas, P., Thompson, J.R., Stefansson, K., Roberts, R., Thorsteinsdottir, U., O'Donnell, C.J., McPherson, R., Erdmann, J., Samani, N.J., Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43:4 (2011), 333–338.
297. Wang, W., Tang, Y., Wang, Y., Tascau, L., Balcerek, J., Tong, W., Levine, R.L., Welch, C., Tall, A.R., Wang, N., LNK/SH2B3 loss of function promotes atherosclerosis and thrombosis. Circ. Res. 119:6 (2016), e91–e103.
298. Dale, B.L., Madhur, M.S., Linking inflammation and hypertension via LNK/SH2B3. Curr. Opin. Nephrol. Hypertens. 25:2 (2016), 87–93.
299. Hung, R.J., Ulrich, C.M., Goode, E.L., Brhane, Y., Muir, K., Chan, A.T., Le Marchand, L., Schildkraut, J., Witte, J.S., Eeles, R., Boffetta, P., Spitz, M.R., Poirier, J.G., Rider, D.N., Fridley, B.L., Chen, Z., Haiman, C., Schumacher, F., Easton, D.F., Landi, M.T., Brennan, P., Houlston, R., Christiani, D.C., Field, J.K., Bickeböller, H., Risch, A., Kote-Jarai, Z., Wiklund, F., Grönberg, H., Chanock, S., Berndt, S.I., Kraft, P., Lindström, S., Al Olama, A.A., Song, H., Phelan, C., Wentzensen, N., Peters, U., Slattery, M.L., Sellers, T.A., Casey, G., Gruber, S.B., Hunter, D.J., Amos, C.I., Henderson, B., Cross cancer genomic investigation of inflammation pathway for five common cancers: lung, ovary, prostate, breast, and colorectal cancer. J. Natl. Cancer Inst., 107(11), 2015.
300. Ding, L.-W., Sun, Q.-Y., Lin, D.-C., Chien, W., Hattori, N., Dong, X.-M., Gery, S., Garg, M., Doan, N.B., Said, J.W., Xiao, J.-F., Yang, H., Liu, L.-Z., Meng, X., Huang, R.Y.-J., Tang, K., Koeffler, H.P., LNK (SH2B3): paradoxical effects in ovarian cancer. Oncogene 34:11 (2015), 1463–1474.
301. Takaki, S., Watts, J.D., Forbush, K.A., Nguyen, N.T., Hayashi, J., Alberola-Ila, J., Aebersold, R., Perlmutter, R.M., Characterization of Lnk. An adaptor protein expressed in lymphocytes. J. Biol. Chem. 272:23 (1997), 14562–14570.
302. https://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/av.cgi?exdb=AceView&db=36a&term=SH2B3.
303. Takizawa, H., Eto, K., Yoshikawa, A., Nakauchi, H., Takatsu, K., Takaki, S., Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals. Exp. Hematol. 36:7 (2008), 897–906.
304. Cheng, Y., Chikwava, K., Wu, C., Zhang, H., Bhagat, A., Pei, D., Choi, J.K., Tong, W., LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors. J. Clin. Invest. 126:4 (2016), 1267–1281.
305. Takaki, S., Morita, H., Tezuka, Y., Takatsu, K., Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk. J. Exp. Med. 195:2 (2002), 151–160.
306. Chatelais, M., Devallière, J., Galli, C., Charreau, B., Gene transfer of the adaptor Lnk (SH2B3) prevents porcine endothelial cell activation and apoptosis: implication for xenograft's cytoprotection. Xenotransplantation 18:2 (2011), 108–120.
307. Lee, J.H., Ji, S.T., Kim, J., Takaki, S., Asahara, T., Hong, Y.-J., Kwon, S.-M., Specific disruption of Lnk in murine endothelial progenitor cells promotes dermal wound healing via enhanced vasculogenesis, activation of myofibroblasts, and suppression of inflammatory cell recruitment. Stem Cell Res Ther, 7(1), 2016, 158.
308. Fortney, K., Dobriban, E., Garagnani, P., Pirazzini, C., Monti, D., Mari, D., Atzmon, G., Barzilai, N., Franceschi, C., Owen, A.B., Kim, S.K., Genome-wide scan informed by age-related disease identifies loci for exceptional human longevity. PLoS Genet., 11(12), 2015, e1005728.
309. Perez-Garcia, A., Ambesi-Impiombato, A., Hadler, M., Rigo, I., LeDuc, C.A., Kelly, K., Jalas, C., Paietta, E., Racevskis, J., Rowe, J.M., Tallman, M.S., Paganin, M., Basso, G., Tong, W., Chung, W.K., Ferrando, A.A., Genetic loss of SH2B3 in acute lymphoblastic leukemia. Blood 122:14 (2013), 2425–2432.
310. Caliceti, C., Nigro, P., Rizzo, P., Ferrari, R., ROS, Notch, and Wnt signaling pathways: crosstalk between three major regulators of cardiovascular biology. Biomed. Res. Int., 2014, 2014, 318714.
311. Oh, S.T., When the brakes are lost: LNK dysfunction in mice, men, and myeloproliferative neoplasms. Ther. Adv. Hematol. 2:1 (2011), 11–19.
312. Lindqvist, C.M., Lundmark, A., Nordlund, J., Freyhult, E., Ekman, D., Carlsson Almlöf, J., Raine, A., Övernäs, E., Abrahamsson, J., Frost, B.-M., Grandér, D., Heyman, M., Palle, J., Forestier, E., Lönnerholm, G., Berglund, E.C., Syvänen, A.-C., Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes. Oncotarget 7:39 (2016), 64071–64088.
313. Hales, E.C., Taub, J.W., Matherly, L.H., New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia. Cell. Signal. 26:1 (2014), 149–161.
314. Lee, S.H., Lee, K.B., Lee, J.H., Kang, S., Kim, H.G., Asahara, T., Kwon, S.M., Selective interference targeting of Lnk in umbilical cord-derived late endothelial progenitor cells improves vascular repair, following hind limb ischemic injury, via regulation of JAK2/STAT3 signaling. Stem Cells 33:5 (2015), 1490–1500.
315. Kwon, S.-M., Lee, Y.-K., Yokoyama, A., Jung, S.-Y., Masuda, H., Kawamoto, A., Lee, Y.M., Asahara, T., Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization. J. Mol. Cell. Cardiol. 51:3 (2011), 308–317.
316. Kim, H., Kim, S., Baek, S.H., Kwon, S.-M., Pivotal cytoprotective mediators and promising therapeutic strategies for endothelial progenitor cell-based cardiovascular regeneration. Stem Cells Int., 2016, 2016, 8340257.
317. CHMP, MACI - Matrix applied characterised autologous cultured chondrocytes. 2013.
318. Martin-Rendon, E., Meta-analyses of human cell-based cardiac regeneration therapies: what can systematic reviews tell us about cell therapies for ischemic heart disease?. Circ. Res. 118:8 (2016), 1264–1272.
319. CHMP, Spherox: spheroids of human autologous matrix-associated chondrocytes. (EMA/CHMP/304021/2017). 2017.
320. CHMP, Holoclar. 2015.
321. CHMP, Glybera, INN - alipogene tiparvovec. 2012.
322. CHMP, Imlygic, INN - talimogene laherparepvec. 2016.
323. CHMP, Strimvelis, Common name - autologous CD34 + enriched cell fraction that contains CD34 + cells transduced with retroviral vector that encodes for the human ADA cDNA sequence. 2016.
324. CHMP, Zalmoxis, common name: allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2). 2016.
325. Vestergaard, H.T., Apote, L.D., Schneider, C.K., Herberts, C., The evolution of nonclinical regulatory science: advanced therapy medicinal products as a paradigm. Mol. Ther. 21:9 (2013), 1644–1648.
326. European Medicines Agency, Advanced Therapy Medicines: Exploring Solutions to Foster Development and Expand Patient Access in Europe (EMA/345874). 2016.
327. Fujita, Y., Kawamoto, A., Regenerative medicine legislation in Japan for fast provision of cell therapy products. Clin. Pharmacol. Ther. 99:1 (2016), 26–29.
328. Corbett, M.S., Webster, A., Hawkins, R., Woolacott, N., Innovative regenerative medicines in the EU: a better future in evidence?. BMC Med., 15(1), 2017, 49.
329. Maciulaitis, R., D'Apote, L., Buchanan, A., Pioppo, L., Schneider, C.K., Clinical development of advanced therapy medicinal products in Europe: evidence that regulators must be proactive. Mol. Ther. 20:3 (2012), 479–482.
330. Foley, L., Whitaker, M., Concise review: cell therapies: the route to widespread adoption. Stem Cells Transl. Med. 1:5 (2012), 438–447.
331. Trindade, F., Leite-Moreira, A., Ferreira-Martins, J., Ferreira, R., Falcao-Pires, I., Vitorino, R., Towards the standardization of stem cell therapy studies for ischemic heart diseases: bridging the gap between animal models and the clinical setting. Int. J. Cardiol. 228 (2017), 465–480.
332. Wollert, K.C., Meyer, G.P., Müller-Ehmsen, J., Tschöpe, C., Bonarjee, V., Larsen, A.I., May, A.E., Empen, K., Chorianopoulos, E., Tebbe, U., Waltenberger, J., Mahrholdt, H., Ritter, B., Pirr, J., Fischer, D., Korf-Klingebiel, M., Arseniev, L., Heuft, H.-G., Brinchmann, J.E., Messinger, D., Hertenstein, B., Ganser, A., Katus, H.A., Felix, S.B., Gawaz, M.P., Dickstein, K., Schultheiss, H.-P., Ladage, D., Greulich, S., Bauersachs, J., Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial. Eur. Heart J., 2017, Apr 19, 10.1093/eurheartj/ehx188.
333. Editorial, A futile cycle in cell therapy. Nat. Biotechnol., 35(4), 2017, 291.
334. Connolly, R., O'Brien, T., Flaherty, G., Stem cell tourism—a web-based analysis of clinical services available to international travellers. Travel Med. Infect. Dis. 12:6 Pt B (2014), 695–701.
335. Wolkenhauer, O., Why model?. Front. Physiol., 5, 2014, 21.
336. Montecucco, F., Carbone, F., Dini, F.L., Fiuza, M., Pinto, F.J., Martelli, A., Palombo, D., Sambuceti, G., Mach, F., de Caterina, R., Implementation strategies of systems medicine in clinical research and home care for cardiovascular disease patients. Eur. J. Intern. Med. 25:9 (2014), 785–794.
337. Björnson, E., Borén, J., Mardinoglu, A., Personalized Cardiovascular Disease Prediction and Treatment-A Review of Existing Strategies and Novel Systems Medicine Tools. 2016.
338. Lysenko, A., Roznovăţ, I.A., Saqi, M., Mazein, A., Rawlings, C.J., Auffray, C., Representing and querying disease networks using graph databases. BioData Min., 9, 2016, 23.
339. Pareja-Tobes, P., Tobes, R., Manrique, M., Pareja, E., Pareja-Tobes, E., Bio4j: A High-Performance Cloud-Enabled Graph-Based Data Platform, bioRxiv. 2015.
340. Wolstencroft, K., Owen, S., Krebs, O., Nguyen, Q., Stanford, N.J., Golebiewski, M., Weidemann, A., Bittkowski, M., An, L., Shockley, D., Snoep, J.L., Mueller, W., Goble, C., SEEK: a systems biology data and model management platform. BMC Syst. Biol., 9, 2015, 33.
341. Ehret, G.B., Munroe, P.B., Rice, K.M., Bochud, M., Johnson, A.D., Chasman, D.I., Smith, A.V., Tobin, M.D., Verwoert, G.C., Hwang, S.-J., Pihur, V., Vollenweider, P., O'Reilly, P.F., Amin, N., Bragg-Gresham, J.L., Teumer, A., Glazer, N.L., Launer, L., Zhao, J.H., Aulchenko, Y., Heath, S., Sõber, S., Parsa, A., Luan, J., Arora, P., Dehghan, A., Zhang, F., Lucas, G., Hicks, A.A., Jackson, A.U., Peden, J.F., Tanaka, T., Wild, S.H., Rudan, I., Igl, W., Milaneschi, Y., Parker, A.N., Fava, C., Chambers, J.C., Fox, E.R., Kumari, M., Go, M.J., van der Harst, P., Kao, W.H.L., Sjögren, M., Vinay, D.G., Alexander, M., Tabara, Y., Shaw-Hawkins, S., Whincup, P.H., Liu, Y., Shi, G., Kuusisto, J., Tayo, B., Seielstad, M., Sim, X., Nguyen, K.-D.H., Lehtimäki, T., Matullo, G., Wu, Y., Gaunt, T.R., Onland-Moret, N.C., Cooper, M.N., Platou, C.G.P., Org, E., Hardy, R., Dahgam, S., Palmen, J., Vitart, V., Braund, P.S., Kuznetsova, T., Uiterwaal, C.S.P.M., Adeyemo, A., Palmas, W., Campbell, H., Ludwig, B., Tomaszewski, M., Tzoulaki, I., Palmer, N.D., Aspelund, T., Garcia, M., Chang, Y.-P.C., O'Connell, J.R., Steinle, N.I., Grobbee, D.E., Arking, D.E., Kardia, S.L., Morrison, A.C., Hernandez, D., Najjar, S., McArdle, W.L., Hadley, D., Brown, M.J., Connell, J.M., Hingorani, A.D., Day, I.N.M., Lawlor, D.A., Beilby, J.P., Lawrence, R.W., Clarke, R., Hopewell, J.C., Ongen, H., Dreisbach, A.W., Li, Y., Young, J.H., Bis, J.C., Kähönen, M., Viikari, J., Adair, L.S., Lee, N.R., Chen, M.-H., Olden, M., Pattaro, C., Bolton, J.A.H., Köttgen, A., Bergmann, S., Mooser, V., Chaturvedi, N., Frayling, T.M., Islam, M., Jafar, T.H., Erdmann, J., Kulkarni, S.R., Bornstein, S.R., Grässler, J., Groop, L., Voight, B.F., Kettunen, J., Howard, P., Taylor, A., Guarrera, S., Ricceri, F., Emilsson, V., Plump, A., Barroso, I., Khaw, K.-T., Weder, A.B., Hunt, S.C., Sun, Y.V., Bergman, R.N., Collins, F.S., Bonnycastle, L.L., Scott, L.J., Stringham, H.M., Peltonen, L., Perola, M., Vartiainen, E., Brand, S.-M., Staessen, J.A., Wang, T.J., Burton, P.R., Soler Artigas, M., Dong, Y., Snieder, H., Wang, X., Zhu, H., Lohman, K.K., Rudock, M.E., Heckbert, S.R., Smith, N.L., Wiggins, K.L., Doumatey, A., Shriner, D., Veldre, G., Viigimaa, M., Kinra, S., Prabhakaran, D., Tripathy, V., Langefeld, C.D., Rosengren, A., Thelle, D.S., Corsi, A.M., Singleton, A., Forrester, T., Hilton, G., McKenzie, C.A., Salako, T., Iwai, N., Kita, Y., Ogihara, T., Ohkubo, T., Okamura, T., Ueshima, H., Umemura, S., Eyheramendy, S., Meitinger, T., Wichmann, H.-E., Cho, Y.S., Kim, H.-L., Lee, J.-Y., Scott, J., Sehmi, J.S., Zhang, W., Hedblad, B., Nilsson, P., Smith, G.D., Wong, A., Narisu, N., Stančáková, A., Raffel, L.J., Yao, J., Kathiresan, S., O'Donnell, C.J., Schwartz, S.M., Ikram, M.A., Longstreth, W.T., Mosley, T.H., Seshadri, S., Shrine, N.R.G., Wain, L.V., Morken, M.A., Swift, A.J., Laitinen, J., Prokopenko, I., Zitting, P., Cooper, J.A., Humphries, S.E., Danesh, J., Rasheed, A., Goel, A., Hamsten, A., Watkins, H., Bakker, S.J.L., van Gilst, W.H., Janipalli, C.S., Mani, K.R., Yajnik, C.S., Hofman, A., Mattace-Raso, F.U.S., Oostra, B.A., Demirkan, A., Isaacs, A., Rivadeneira, F., Lakatta, E.G., Orru, M., Scuteri, A., Ala-Korpela, M., Kangas, A.J., Lyytikäinen, L.-P., Soininen, P., Tukiainen, T., Würtz, P., Ong, R.T.-H., Dörr, M., Kroemer, H.K., Völker, U., Völzke, H., Galan, P., Hercberg, S., Lathrop, M., Zelenika, D., Deloukas, P., Mangino, M., Spector, T.D., Zhai, G., Meschia, J.F., Nalls, M.A., Sharma, P., Terzic, J., Kumar, M.V.K., Denniff, M., Zukowska-Szczechowska, E., Wagenknecht, L.E., Fowkes, F.G.R., Charchar, F.J., Schwarz, P.E.H., Hayward, C., Guo, X., Rotimi, C., Bots, M.L., Brand, E., Samani, N.J., Polasek, O., Talmud, P.J., Nyberg, F., Kuh, D., Laan, M., Hveem, K., Palmer, L.J., van der Schouw, Y.T., Casas, J.P., Mohlke, K.L., Vineis, P., Raitakari, O., Ganesh, S.K., Wong, T.Y., Tai, E.S., Cooper, R.S., Laakso, M., Rao, D.C., Harris, T.B., Morris, R.W., Dominiczak, A.F., Kivimaki, M., Marmot, M.G., Miki, T., Saleheen, D., Chandak, G.R., Coresh, J., Navis, G., Salomaa, V., Han, B.-G., Zhu, X., Kooner, J.S., Melander, O., Ridker, P.M., Bandinelli, S., Gyllensten, U.B., Wright, A.F., Wilson, J.F., Ferrucci, L., Farrall, M., Tuomilehto, J., Pramstaller, P.P., Elosua, R., Soranzo, N., Sijbrands, E.J.G., Altshuler, D., Loos, R.J.F., Shuldiner, A.R., Gieger, C., Meneton, P., Uitterlinden, A.G., Wareham, N.J., Gudnason, V., Rotter, J.I., Rettig, R., Uda, M., Strachan, D.P., Witteman, J.C.M., Hartikainen, A.-L., Beckmann, J.S., Boerwinkle, E., Vasan, R.S., Boehnke, M., Larson, M.G., Järvelin, M.-R., Psaty, B.M., Abecasis, G.R., Chakravarti, A., Elliott, P., van Duijn, C.M., Newton-Cheh, C., Levy, D., Caulfield, M.J., Johnson, T., Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478:7367 (2011), 103–109.
342. Wang, H., Chen, Y., Li, X., Chen, G., Zhong, L., Chen, G., Liao, Y., Liao, W., Bin, J., Genome-wide analysis of alternative splicing during human heart development. Sci Rep, 6(1), 2016, 35520.
343. Chen, K., Dai, X., Wu, J., Alternative splicing: an important mechanism in stem cell biology. World J. Stem Cells 7:1 (2015), 1–10.
344. Huan, T., Esko, T., Peters, M.J., Pilling, L.C., Schramm, K., Schurmann, C., Chen, B.H., Liu, C., Joehanes, R., Johnson, A.D., Yao, C., Ying, S.-X., Courchesne, P., Milani, L., Raghavachari, N., Wang, R., Liu, P., Reinmaa, E., Dehghan, A., Hofman, A., Uitterlinden, A.G., Hernandez, D.G., Bandinelli, S., Singleton, A., Melzer, D., Metspalu, A., Carstensen, M., Grallert, H., Herder, C., Meitinger, T., Peters, A., Roden, M., Waldenberger, M., Dörr, M., Felix, S.B., Zeller, T., Vasan, R., O'Donnell, C.J., Munson, P.J., Yang, X., Prokisch, H., Völker, U., van Meurs, Joyce B.J., Ferrucci, L., Levy, D., McCarthy, M.I., A meta-analysis of gene expression signatures of blood pressure and hypertension. PLoS Genet., 11(3), 2015, e1005035.
345. Huan, T., Meng, Q., Saleh, M.A., Norlander, A.E., Joehanes, R., Zhu, J., Chen, B.H., Zhang, B., Johnson, A.D., Ying, S., Courchesne, P., Raghavachari, N., Wang, R., Liu, P., International Consortium for Blood Pressure GWAS, O'Donnell, C.J., Vasan, R., Munson, P.J., Madhur, M.S., Harrison, D.G., Yang, X., Levy, D., Integrative network analysis reveals molecular mechanisms of blood pressure regulation. Mol. Syst. Biol., 11(1), 2015, 799.
346. Zhu, T., Qiao, L., Wang, Q., Mi, R., Chen, J., Lu, Y., Gu, J., Zheng, Q., T-box family of transcription factor-TBX5, insights in development and disease. Am. J. Transl. Res. 9:2 (2017), 442–453.
347. Ounzain, S., Micheletti, R., Beckmann, T., Schroen, B., Alexanian, M., Pezzuto, I., Crippa, S., Nemir, M., Sarre, A., Johnson, R., Dauvillier, J., Burdet, F., Ibberson, M., Guigó, R., Xenarios, I., Heymans, S., Pedrazzini, T., Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs. Eur. Heart J., 36(6), 2015 (353-68a).
348. Mathiyalagan, P., Keating, S.T., Du, X.-J., El-Osta, A., Interplay of chromatin modifications and non-coding RNAs in the heart. Epigenetics 9:1 (2014), 101–112.
349. Lott, S.C., Wolfien, M., Riege, K., Bagnacani, A., Wolkenhauer, O., Hoffmann, S., Hess, W.R., Customized workflow development and data modularization concepts for RNA-sequencing and metatranscriptome experiments. J. Biotechnol., 2017.
350. Lampa, S., Dahlö, M., Olason, P.I., Hagberg, J., Spjuth, O., Lessons learned from implementing a national infrastructure in Sweden for storage and analysis of next-generation sequencing data. GigaScience, 2(1), 2013, 9.
351. Afgan, E., Baker, D., van den Beek, M., Blankenberg, D., Bouvier, D., Čech, M., Chilton, J., Clements, D., Coraor, N., Eberhard, C., Grüning, B., Guerler, A., Hillman-Jackson, J., Von Kuster, G., Rasche, E., Soranzo, N., Turaga, N., Taylor, J., Nekrutenko, A., Goecks, J., The galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 44:W1 (2016), W3–W10.
352. Grüning, B.A., Fallmann, J., Yusuf, D., Will, S., Erxleben, A., Eggenhofer, F., Houwaart, T., Batut, B., Videm, P., Bagnacani, A., Wolfien, M., Lott, S.C., Hoogstrate, Y., Hess, W.R., Wolkenhauer, O., Hoffmann, S., Akalin, A., Ohler, U., Stadler, P.F., Backofen, R., The RNA workbench: best practices for RNA and high-throughput sequencing bioinformatics in galaxy. Nucleic Acids Res. 45 (2017), D626–D634.
353. Wolfien, M., Rimmbach, C., Schmitz, U., Jung, J.J., Krebs, S., Steinhoff, G., David, R., Wolkenhauer, O., TRAPLINE: a standardized and automated pipeline for RNA sequencing data analysis, evaluation and annotation. BMC Bioinformatics, 17, 2016, 21.
354. Grüning, B.A., Rasche, E., Rebolledo-Jaramillo, B., Eberhard, C., Houwaart, T., Chilton, J., Coraor, N., Backofen, R., Taylor, J., Nekrutenko, A., Jupyter and galaxy: easing entry barriers into complex data analyses for biomedical researchers. PLoS Comput. Biol., 13(5), 2017, e1005425.
355. Lusis, A.J., Weiss, J.N., Cardiovascular networks: systems-based approaches to cardiovascular disease. Circulation 121:1 (2010), 157–170.
356. Gambardella, G., Moretti, M.N., de Cegli, R., Cardone, L., Peron, A., Di Bernardo, D., Differential network analysis for the identification of condition-specific pathway activity and regulation. Bioinformatics 29:14 (2013), 1776–1785.
357. Menche, J., Sharma, A., Kitsak, M., Ghiassian, S.D., Vidal, M., Loscalzo, J., Barabási, A.-L., Disease networks. Uncovering disease-disease relationships through the incomplete interactome. Science (New York, N.Y.), 347(6224), 2015 (1257601).
358. Liu, J., Jing, L., Tu, X., Weighted gene co-expression network analysis identifies specific modules and hub genes related to coronary artery disease. BMC Cardiovasc. Disord., 16, 2016, 54.
359. Ballouz, S., Verleyen, W., Gillis, J., Guidance for RNA-seq co-expression network construction and analysis: safety in numbers. Bioinformatics 31:13 (2015), 2123–2130.
360. Goff, D.C., Lloyd-Jones, D.M., Bennett, G., Coady, S., D'Agostino, R.B., Gibbons, R., Greenland, P., Lackland, D.T., Levy, D., O'Donnell, C.J., Robinson, J.G., Schwartz, J.S., Shero, S.T., Smith, S.C., Sorlie, P., Stone, N.J., Wilson, P.W.F., 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63:25 Pt B (2014), 2935–2959.
361. Weng, S.F., Reps, J., Kai, J., Garibaldi, J.M., Qureshi, N., Leufkens, H.G., Liu, B., Can machine-learning improve cardiovascular risk prediction using routine clinical data?. PLoS One, 12(4), 2017, e0174944.
362. Obermeyer, Z., Emanuel, E.J., Predicting the future — big data, machine learning, and clinical medicine. N. Engl. J. Med. 375:13 (2016), 1216–1219.
363. Dreiseitl, S., Ohno-Machado, L., Logistic regression and artificial neural network classification models: a methodology review. J. Biomed. Inform. 35:5–6 (2002), 352–359.
364. Shah, A.M., Claggett, B., Sweitzer, N.K., Shah, S.J., Anand, I.S., Liu, L., Pitt, B., Pfeffer, M.A., Solomon, S.D., Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone. Circulation 132:5 (2015), 402–414.
365. Vrijhoef, H.J., de Belvis, A.G., de La Calle, M., de Sabata, M.S., Hauck, B., Montante, S., Moritz, A., Pelizzola, D., Saraheimo, M., Guldemond, N.A., IT-supported integrated care pathways for diabetes: a compilation and review of good practices. Int. J. Care Coord. 20:1–2 (2017), 26–40.
366. Sengupta, P.P., Huang, Y.-M., Bansal, M., Ashrafi, A., Fisher, M., Shameer, K., Gall, W., Dudley, J.T., Cognitive machine-learning algorithm for cardiac imaging: a pilot study for differentiating constrictive pericarditis from restrictive cardiomyopathy. Circ. Cardiovasc. Imaging, 9(6), 2016.
367. Jansen of Lorkeers, Sanne J., Doevendans, P.A., Chamuleau, S.A.J., All preclinical trials should be registered in advance in an online registry. Eur. J. Clin. Investig. 44:9 (2014), 891–892.
368. Nowbar, A.N., Mielewczik, M., Karavassilis, M., Dehbi, H.-M., Shun-Shin, M.J., Jones, S., Howard, J.P., Cole, G.D., Francis, D.P., Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ, 348, 2014, g2688.
369. Louria-Hayon, I., Frelin, C., Ruston, J., Gish, G., Jin, J., Kofler, M.M., Lambert, J.-P., Adissu, H.A., Milyavsky, M., Herrington, R., Minden, M.D., Dick, J.E., Gingras, A.-C., Iscove, N.N., Pawson, T., Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling. Proc. Natl. Acad. Sci. U. S. A. 110:51 (2013), 20599–20604.
370. Ishige-Wada, M., Kwon, S.-M., Eguchi, M., Hozumi, K., Iwaguro, H., Matsumoto, T., Fukuda, N., Mugishima, H., Masuda, H., Asahara, T., Jagged-1 signaling in the bone marrow microenvironment promotes endothelial progenitor cell expansion and commitment of CD133 + human cord blood cells for postnatal Vasculogenesis. PLoS One, 11(11), 2016, e0166660.
371. Fitau, J., Boulday, G., Coulon, F., Quillard, T., Charreau, B., The adaptor molecule Lnk negatively regulates tumor necrosis factor-alpha-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and -2 pathways. J. Biol. Chem. 281:29 (2006), 20148–20159.
372. Gueller, S., Hehn, S., Nowak, V., Gery, S., Serve, H., Brandts, C.H., Koeffler, H.P., Adaptor protein Lnk binds to PDGF receptor and inhibits PDGF-dependent signaling. Exp. Hematol. 39:5 (2011), 591–600.
373. Auer, P.L., Teumer, A., Schick, U., O'Shaughnessy, A., Lo, K.S., Chami, N., Carlson, C., de Denus, S., Dubé, M.-P., Haessler, J., Jackson, R.D., Kooperberg, C., Perreault, L.-P.L., Nauck, M., Peters, U., Rioux, J.D., Schmidt, F., Turcot, V., Völker, U., Völzke, H., Greinacher, A., Hsu, L., Tardif, J.-C., Diaz, G.A., Reiner, A.P., Lettre, G., Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traits. Nat. Genet. 46:6 (2014), 629–634.
374. McPherson, R., Tybjaerg-Hansen, A., Genetics of coronary artery disease. Circ. Res. 118:4 (2016), 564–578.
375. Lavrikova, E.Y., Nikitin, A.G., Kuraeva, T.L., Peterkova, V.A., Tsitlidze, N.M., Chistiakov, D.A., Nosikov, V.V., The carriage of the type 1 diabetes-associated R262W variant of human LNK correlates with increased proliferation of peripheral blood monocytes in diabetic patients. Pediatr. Diabetes 12:2 (2011), 127–132.
376. Kwon, S.-M., Suzuki, T., Kawamoto, A., Ii, M., Eguchi, M., Akimaru, H., Wada, M., Matsumoto, T., Masuda, H., Nakagawa, Y., Nishimura, H., Kawai, K., Takaki, S., Asahara, T., Pivotal role of lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration. Circ. Res. 104:8 (2009), 969–977.